Call for Tenders SANTE/2020/C3/029 – Supply of Medicinal Products Used for Intensive Care Patients Subject to the Novel Coronavirus (COVID-19) Disease | Tenderlake

Call for Tenders SANTE/2020/C3/029 – Supply of Medicinal Products Used for Intensive Care Patients Subject to the Novel Coronavirus (COVID-19) Disease

Contract Value:
EUR 534M - 534M
Notice Type:
Contract award notice
Published Date:
01 April 2022
Closing Date:
Location(s):
BA BOSNIA AND HERZEGOVINA
BE BELGIQUE-BELGIË (BE Belgium/BELGIQUE-BELGIË)
BG БЪЛГАРИЯ (BULGARIA) (BG Bulgaria/БЪЛГАРИЯ (BULGARIA))
DK DANMARK (DK Denmark/DANMARK)
EE EESTI (EE Estonia/EESTI)
FI SUOMI / FINLAND (FI Finland/SUOMI / FINLAND)
HU MAGYARORSZÁG (HU Hungary/MAGYARORSZÁG)
IT ITALIA (IT Italy/ITALIA)
LI LIECHTENSTEIN
ME ЦРНА ГОРА (CRNA GORA) (ME Montenegro/ЦРНА ГОРА (CRNA GORA))
MK ПОРАНЕШНА ЈУГОСЛОВЕНСКА РЕПУБЛИКА МАКЕДОНИЈА (PORANEŠNA JUGOSLOVENSKA REPUBLIKA MAKEDONIJA) (MK Macedonia, the Former Yugoslav Republic of/ПОРАНЕШНА ЈУГОСЛОВЕНСКА РЕПУБЛИКА МАКЕДОНИЈА (PORANEŠNA JUGOSLOVENSKA REPUBLIKA MAKEDONIJA))
NO NORGE (NO Norway/NORGE)
PT PORTUGAL
RO ROMÂNIA (RO Romania/ROMÂNIA)
SE SVERIGE (SE Sweden/SVERIGE)
SI SLOVENIJA (SI Slovenia/SLOVENIJA)
UK UNITED KINGDOM
Description:
Call for Tenders SANTE/2020/C3/029 – Supply of Medicinal Products Used for Intensive Care Patients Subject to the Novel Coronavirus (COVID-19) Disease

The subject of this call for tenders is the supply of medicinal products used for patients in intensive care unit (ICU) subject to the novel coronavirus (COVID-19) disease. It covers 24 medicinal products, grouped under six categories, namely: analgesics/corticosteroids, antibiotics, muscle relaxers, anaesthetics/sedatives, resuscitation drugs / emergency and other medications.


Dexamethasone – Category I: Analgesics/Corticosteroids

Dexamethasone 4 mg/ml, 1 ml.


Morphine – Category I: Analgesics/Corticosteroids

Morphine 50 mg/ml, 50 ml.


Morphine – Category I: Analgesics/Corticosteroids

Morphine 60 mg/ml, 1 ml.


Morphine – Category I: Analgesics/Corticosteroids

Morphine 100 mg/ml, 5 ml.


Paracetamol – Category I: Analgesics/Corticosteroids

Paracetamol 10 mg/ml, 100 ml.


Remifentanil – Category I: Analgesics/Corticosteroids

Remifentanil 1 mg.


Remifentanil – Category I: Analgesics/Corticosteroids

Remifentanil 2 mg.


Remifentanil – Category I: Analgesics/Corticosteroids

Remifentanil 5 mg.


Sufentanil – Category I: Analgesics/Corticosteroids

Sufentanil 5 mcg/ml, 1 ml.


Sufentanil – Category I: Analgesics/Corticosteroids

Sufentanil 5 mcg/ml, 10 ml.


Sufentanil – Category I: Analgesics/Corticosteroids

Sufentanil 50 mcg/ml, 5 ml.


Fentanyl – Category I: Analgesics/Corticosteroids

Fentanyl 50 mcg/ml, 1 ml.


Amoxicillin Sodium / Potassium Clavulanate – Category II: Antibiotics

Amoxicillin sodium / Potassium clavulanate 1 g/100 mg, 10 ml.


Amoxicillin Sodium / Potassium Clavulanate – Category II: Antibiotics

Amoxicillin sodium / Potassium clavulanate 1 g/200 mg, 10 ml.


Azithromycin – Category II: Antibiotics

Azithromycin 500 mg/10 ml.


Ceftriaxone – Category II: Antibiotics

Ceftriaxone 1 g/10 ml vials.


Ceftriaxone – Category II: Antibiotics

Ceftriaxone 2 g/10 ml vials.


Levofloxacin – Category II: Antibiotics

Levofloxacin 5 mg/1 ml/50 ml.


Levofloxacin - CATEGORY II Antibiotics

Levofloxacin 5 mg/1 ml/100 ml.


Piperacillin and Tazobactam – Category II: Antibiotics

Piperacillin and tazobactam 2 g and 0,25 g/50 ml.


Piperacillin and Tazobactam – Category II: Antibiotics

Piperacillin and tazobactam 4 g and 0,5 g/100 ml.


Atracurium – Category III: Muscle Relaxers

Atracurium 10 mg/ml, 2,5 ml.


Fentanyl – Category I: Analgesics/Corticosteroids

Fentanyl 50 mcg/ml, 2 ml.


Atracurium – Category III: Muscle Relaxers

Atracurium 10 mg/ml, 5 ml.


Atracurium – Category III: Muscle Relaxers

Atracurium 10 mg/ml, 25 ml.


Cisatracurium – Category III: Muscle Relaxers

Cisatracurium 2 mg/ml, 5 ml.


Cisatracurium – Category III: Muscle Relaxers

Cisatracurium 2 mg/ml, 10 ml.


Mivacurium – Category III: Muscle Relaxers

Mivacurium 2 mg/ml, 10 ml.


Rocuronium – Category III: Muscle Relaxers

Rocuronium 10 mg/ml, 5 ml.


Rocuronium – Category III: Muscle Relaxers

Rocuronium 10 mg/ml, 10 ml.


Dexmedetomidine – Category IV: Anaesthetics/Sedatives

Dexmedetomidine 100 mcg/ml, 2 ml.


Dexmedetomidine – Category IV: Anaesthetics/Sedatives

Dexmedetomidine 100 mcg/ml, 4 ml.


Dexmedetomidine – Category IV: Anaesthetics/Sedatives

Dexmedetomidine 100 mcg/ml, 10 ml.


Fentanyl – Category I: Analgesics/Corticosteroids

Fentanyl 50 mcg/ml, 5 ml.


Dexmedetomidine – Category IV: Anaesthetics/Sedatives

Dexmedetomidine 100 mcg/ml, 25 ml.


Lorazepam – Category IV: Anaesthetics/Sedatives

Lorazepam 4 mg/ml, 1 ml.


Midazolam – Category IV: Anaesthetics/Sedatives

Midazolam 1 mg/ml, 5 ml.


Midazolam – Category IV: Anaesthetics/Sedatives

Midazolam 2 mg/ml, 50 ml.


Midazolam – Category IV: Anaesthetics/Sedatives

Midazolam 5 mg/ml, 1 ml.


Midazolam – Category IV: Anaesthetics/Sedatives

Midazolam 5 mg/ml, 2 ml.


Midazolam – Category IV: Anaesthetics/Sedatives

Midazolam 5 mg/ml, 3 ml.


Midazolam – Category IV: Anaesthetics/Sedatives

Midazolam 5 mg/ml, 5 ml.


Midazolam – Category IV: Anaesthetics/Sedatives

Midazolam 5 mg/ml, 10 ml.


Propofol – Category IV: Anaesthetics/Sedatives

Propofol 10 mg/ml, 10 ml.


Fentanyl – Category I: Analgesics/Corticosteroids

Fentanyl 500 mcg/ml, 10 ml.


Propofol – Category IV: Anaesthetics/Sedatives

Propofol 10 mg/ml, 20 ml.


Propofol – Category IV: Anaesthetics/Sedatives

Propofol 10 mg/ml, 50 ml.


Propofol – Category IV: Anaesthetics/Sedatives

Propofol 10 mg/ml, 100 ml.


Propofol – Category IV: Anaesthetics/Sedatives

Propofol 20 mg/ml, 50 ml.


Dobutamine – Category V: Resuscitation Drugs / Emergency

Dobutamine 50 mg/ml, 5 ml.


Dobutamine – Category V: Resuscitation Drugs / Emergency

Dobutamine 5 mg/ml, 50 ml.


Dopamine Hydrochloride – Category V: Resuscitation Drugs / Emergency

Dopamine hydrochloride 40 mg/1 ml, 5 ml.


Dopamine Hydrochloride – Category V: Resuscitation Drugs / Emergency

Dopamine hydrochloride 200 mg/ml, 5 ml.


Epinephrine/Adrenaline – Category V: Resuscitation Drugs / Emergency

Epinephrine/adrenaline 1 mg/ml, 1 ml.


Epinephrine/Adrenaline – Category V: Resuscitation Drugs / Emergency

Epinephrine/adrenaline 1 mg/ml, 10 ml.


Fentanyl – Category I: Analgesics/Corticosteroids

Fentanyl 50 mcg/ml, 10 ml.


Norepinephrine/Noradrenaline – Category V: Resuscitation Drugs / Emergency

Norepinephrine/noradrenaline 1 mg/ml, 1 ml.


Norepinephrine/Noradrenaline – Category V: Resuscitation Drugs / Emergency

Norepinephrine/noradrenaline 1 mg/ml, 4 ml.


Norepinephrine/Noradrenaline – Category V: Resuscitation Drugs / Emergency

Norepinephrine/noradrenaline 2 mg/ml, 1 ml.


Norepinephrine/Noradrenaline – Category V: Resuscitation Drugs / Emergency

Norepinephrine/noradrenaline 2 mg/ml, 4 ml.


Norepinephrine/Noradrenaline – Category V: Resuscitation Drugs / Emergency

Norepinephrine/noradrenaline 80 mcg/ml, 50 ml.


Norepinephrine/Noradrenaline – Category V: Resuscitation Drugs / Emergency

Norepinephrine/noradrenaline 1 mg/ml, 50 ml.


Heparin – Category VI: Other Medications

Heparin 5K/1 ml, 5 ml.


Heparin – Category VI: Other Medications

Heparin 25 IU/1 ml, 5 ml.


Heparin – Category VI: Other Medications

Heparin 100 IU/1 ml, 5 ml.


Morphine – Category I: Analgesics/Corticosteroids

Morphine 10 mg/ml, 1 ml.


Morphine – Category I: Analgesics/Corticosteroids

Morphine 20 mg/ml, 1 ml.


Morphine – Category I: Analgesics/Corticosteroids

Morphine 30 mg/ml, 1 ml.

Awarded to:
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexamethasone 4 mg/ml, 1 ml
Accord Health Care BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Accord Health Care BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Accord Health Care BV, Utrecht (NL)
Accord Health Care BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 4 ml
Accord Health Care BV, Utrecht (NL)
Accord Health Care BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 10 ml
Accord Health Care BV, Utrecht (NL)
Accord Health Care BV, Utrecht (NL)
Accord Health Care BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 1 mg/ml, 5 ml
Accord Health Care BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 3 ml
Accord Health Care BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 50 ml
Accord Health Care BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Accord Health Care BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin, 5K/1 ml, 5 ml
Accord Health Care BV, Utrecht (NL)
Accord Health Care BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 5 ml
Accord Health Care BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Accord Health Care BV, Utrecht (NL)
Accord Health Care BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 1 mg
Accord Health Care BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 2 mg
Accord Health Care BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 5 mg
Accord Health Care BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Amoxicillin Sodium / Potassium Clavulanate 1 g/220 mg/10 ml
Accord Health Care BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Azithromycin 500 mg/5 ml
Accord Health Care BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 1 g/10 ml
Accord Health Care BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl Citrate 50 mcg/ml, 2 ml
Accord Health Care BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 1 g/10 ml
Accord Health Care BV, Utrecht (NL)
Accord Health Care BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 2 g/10 ml
Accord Health Care BV, Utrecht (NL)
Accord Health Care BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Levofloxacin, 5 mg/ml/100 ml
Accord Health Care BV, Utrecht (NL)
Accord Health Care BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium, 10 mg/ml, 2,5 ml
Accord Health Care BV, Utrecht (NL)
Accord Health Care BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Piperacillin and Tazobactam, 2 g and 0,25 g/50 ml
Accord Health Care BV, Utrecht (NL)
Accord Health Care BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl Citrate 50 mcg/ml, 10 ml
Accord Health Care BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Piperacillin and Tazobactam, 4 g and 0,5 g/100 ml
Accord Health Care BV, Utrecht (NL)
Accord Health Care BV, Utrecht (NL)
Accord Health Care BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium, 10 mg/ml, 5 ml
Accord Health Care BV, Utrecht (NL)
Accord Health Care BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 5 ml
Accord Health Care BV, Utrecht (NL)
Accord Health Care BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 10 ml
Accord Health Care BV, Utrecht (NL)
Accord Health Care BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Accord Health Care BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 10 mg/ml, 1 ml
Accord Health Care BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Accord Health Care BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Accord Health Care BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 4 ml
Accord Health Care BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 10 ml
Accord Health Care BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 1 mg/ml, 5 ml
Accord Health Care BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 2 mg/ml, 50 ml
Accord Health Care BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 1 ml
Accord Health Care BV, Utrecht (NL)
Accord Health Care BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 3 ml
Accord Health Care BV, Utrecht (NL)
Accord Health Care BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 10 mg/ml, 1 ml
Accord Health Care BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 10 ml
Accord Health Care BV, Utrecht (NL)
Accord Health Care BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 10 ml
Accord Health Care BV, Utrecht (NL)
Accord Health Care BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 50 ml
Accord Health Care BV, Utrecht (NL)
Accord Health Care BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 100 ml
Accord Health Care BV, Utrecht (NL)
Accord Health Care BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 20 mg/ml, 50 ml
Accord Health Care BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 20 mg/ml, 1 ml
Accord Health Care BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dopamine, 40 mg/ml, 5 ml
Accord Health Care BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Epinephrine/Adrenaline, 1 mg/ml, 1 ml
Accord Health Care BV, Utrecht (NL)
Accord Health Care BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 1 mg/ml,1 ml
Accord Health Care BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 1 mg/ml, 4 ml
Accord Health Care BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 2 mg/ml, 1 ml
Accord Health Care BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin, 5K/1 ml, 5 ml
Accord Health Care BV, Utrecht (NL)
Accord Health Care BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 50 mcg/ml 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 500 mcg/ml 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 20 mg/ml, 1 ml
Accord Health Care BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 50 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 60 mg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Amoxicillin sodium/Potassium clavulanate 1 g/100 mg/10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Levofloxacin 5 mg/ml/50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium 10 mg/ml, 25 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Mivacurium 2 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium 10 mg/1 ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine 100 mcg/ml 25 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Lorazepam 4 mg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam 5 mg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 30 mg/ml, 1ml
Accord Health Care BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol 10 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease - Dobutamine 50 mg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dobutamine 5 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dopamine 200 mg/1 ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Epinephrine/Adrenaline 1 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 80 mcg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 1 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin 25 IU/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin 100 IU/ ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 50 mcg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 100 mg/ml, 5 ml
Accord Health Care BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 2 mg/ml, 4 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 50 mcg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 5 mcg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 50 mcg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 2 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 10 ml
Accord Health Care BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Accord Health Care BV, Utrecht (NL)
Accord Health Care BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg /ml 2 ml
Accord Health Care BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Accord Health Care BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexamethasone 4 mg/ml, 1 ml
Accord Healthcare BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Accord Healthcare BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Accord Healthcare BV, Utrecht (NL)
Accord Healthcare BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 4 ml
Accord Healthcare BV, Utrecht (NL)
Accord Healthcare BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 10 ml
Accord Healthcare BV, Utrecht (NL)
Accord Healthcare BV, Utrecht (NL)
Accord Healthcare BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 1 mg/ml, 5 ml
Accord Healthcare BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 3 ml
Accord Healthcare BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 50 ml
Accord Healthcare BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Accord Healthcare BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin, 5K/1 ml, 5 ml
Accord Healthcare BV, Utrecht (NL)
Accord Healthcare BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 5 ml
Accord Healthcare BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Accord Healthcare BV, Utrecht (NL)
Accord Healthcare BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 1 mg
Accord Healthcare BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 2 mg
Accord Healthcare BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 5 mg
Accord Healthcare BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Amoxicillin Sodium / Potassium Clavulanate 1 g/220 mg/10 ml
Accord Healthcare BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Azithromycin 500 mg/5 ml
Accord Healthcare BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 1 g/10 ml
Accord Healthcare BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl Citrate 50 mcg/ml, 2 ml
Accord Healthcare BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 1 g/10 ml
Accord Healthcare BV, Utrecht (NL)
Accord Healthcare BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 2 g/10 ml
Accord Healthcare BV, Utrecht (NL)
Accord Healthcare BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Levofloxacin, 5 mg/ml/100 ml
Accord Healthcare BV, Utrecht (NL)
Accord Healthcare BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium, 10 mg/ml, 2,5 ml
Accord Healthcare BV, Utrecht (NL)
Accord Healthcare BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Piperacillin and Tazobactam, 2 g and 0,25 g/50 ml
Accord Healthcare BV, Utrecht (NL)
Accord Healthcare BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl Citrate 50 mcg/ml, 10 ml
Accord Healthcare BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Piperacillin and Tazobactam, 4 g and 0,5 g/100 ml
Accord Healthcare BV, Utrecht (NL)
Accord Healthcare BV, Utrecht (NL)
Accord Healthcare BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium, 10 mg/ml, 5 ml
Accord Healthcare BV, Utrecht (NL)
Accord Healthcare BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 5 ml
Accord Healthcare BV, Utrecht (NL)
Accord Healthcare BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 10 ml
Accord Healthcare BV, Utrecht (NL)
Accord Healthcare BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Accord Healthcare BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 10 mg/ml, 1 ml
Accord Healthcare BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Accord Healthcare BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Accord Healthcare BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 4 ml
Accord Healthcare BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 10 ml
Accord Healthcare BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 1 mg/ml, 5 ml
Accord Healthcare BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 2 mg/ml, 50 ml
Accord Healthcare BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 1 ml
Accord Healthcare BV, Utrecht (NL)
Accord Healthcare BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 3 ml
Accord Healthcare BV, Utrecht (NL)
Accord Healthcare BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 10 mg/ml, 1 ml
Accord Healthcare BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 10 ml
Accord Healthcare BV, Utrecht (NL)
Accord Healthcare BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 10 ml
Accord Healthcare BV, Utrecht (NL)
Accord Healthcare BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 50 ml
Accord Healthcare BV, Utrecht (NL)
Accord Healthcare BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 100 ml
Accord Healthcare BV, Utrecht (NL)
Accord Healthcare BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 20 mg/ml, 50 ml
Accord Healthcare BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 20 mg/ml, 1 ml
Accord Healthcare BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dopamine, 40 mg/ml, 5 ml
Accord Healthcare BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Epinephrine/Adrenaline, 1 mg/ml, 1 ml
Accord Healthcare BV, Utrecht (NL)
Accord Healthcare BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 1 mg/ml,1 ml
Accord Healthcare BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 1 mg/ml, 4 ml
Accord Healthcare BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 2 mg/ml, 1 ml
Accord Healthcare BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin, 5K/1 ml, 5 ml
Accord Healthcare BV, Utrecht (NL)
Accord Healthcare BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 50 mcg/ml 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 500 mcg/ml 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 20 mg/ml, 1 ml
Accord Healthcare BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 50 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 60 mg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Amoxicillin sodium/Potassium clavulanate 1 g/100 mg/10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Levofloxacin 5 mg/ml/50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium 10 mg/ml, 25 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Mivacurium 2 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium 10 mg/1 ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine 100 mcg/ml 25 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Lorazepam 4 mg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam 5 mg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 30 mg/ml, 1ml
Accord Healthcare BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol 10 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease - Dobutamine 50 mg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dobutamine 5 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dopamine 200 mg/1 ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Epinephrine/Adrenaline 1 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 80 mcg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 1 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin 25 IU/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin 100 IU/ ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 50 mcg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 100 mg/ml, 5 ml
Accord Healthcare BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 2 mg/ml, 4 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 50 mcg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 5 mcg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 50 mcg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 2 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 10 ml
Accord Healthcare BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Accord Healthcare BV, Utrecht (NL)
Accord Healthcare BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg /ml 2 ml
Accord Healthcare BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Accord Healthcare BV, Utrecht (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexamethasone 4 mg/ml, 1 ml
Actavis International, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Actavis International, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Actavis International, Luqa (MT)
Actavis International, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 4 ml
Actavis International, Luqa (MT)
Actavis International, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 10 ml
Actavis International, Luqa (MT)
Actavis International, Luqa (MT)
Actavis International, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 1 mg/ml, 5 ml
Actavis International, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 3 ml
Actavis International, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 50 ml
Actavis International, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Actavis International, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin, 5K/1 ml, 5 ml
Actavis International, Luqa (MT)
Actavis International, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 5 ml
Actavis International, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Actavis International, Luqa (MT)
Actavis International, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 1 mg
Actavis International, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 2 mg
Actavis International, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 5 mg
Actavis International, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Amoxicillin Sodium / Potassium Clavulanate 1 g/220 mg/10 ml
Actavis International, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Azithromycin 500 mg/5 ml
Actavis International, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 1 g/10 ml
Actavis International, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl Citrate 50 mcg/ml, 2 ml
Actavis International, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 1 g/10 ml
Actavis International, Luqa (MT)
Actavis International, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 2 g/10 ml
Actavis International, Luqa (MT)
Actavis International, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Levofloxacin, 5 mg/ml/100 ml
Actavis International, Luqa (MT)
Actavis International, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium, 10 mg/ml, 2,5 ml
Actavis International, Luqa (MT)
Actavis International, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Piperacillin and Tazobactam, 2 g and 0,25 g/50 ml
Actavis International, Luqa (MT)
Actavis International, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl Citrate 50 mcg/ml, 10 ml
Actavis International, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Piperacillin and Tazobactam, 4 g and 0,5 g/100 ml
Actavis International, Luqa (MT)
Actavis International, Luqa (MT)
Actavis International, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium, 10 mg/ml, 5 ml
Actavis International, Luqa (MT)
Actavis International, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 5 ml
Actavis International, Luqa (MT)
Actavis International, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 10 ml
Actavis International, Luqa (MT)
Actavis International, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Actavis International, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 10 mg/ml, 1 ml
Actavis International, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Actavis International, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Actavis International, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 4 ml
Actavis International, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 10 ml
Actavis International, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 1 mg/ml, 5 ml
Actavis International, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 2 mg/ml, 50 ml
Actavis International, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 1 ml
Actavis International, Luqa (MT)
Actavis International, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 3 ml
Actavis International, Luqa (MT)
Actavis International, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 10 mg/ml, 1 ml
Actavis International, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 10 ml
Actavis International, Luqa (MT)
Actavis International, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 10 ml
Actavis International, Luqa (MT)
Actavis International, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 50 ml
Actavis International, Luqa (MT)
Actavis International, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 100 ml
Actavis International, Luqa (MT)
Actavis International, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 20 mg/ml, 50 ml
Actavis International, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 20 mg/ml, 1 ml
Actavis International, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dopamine, 40 mg/ml, 5 ml
Actavis International, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Epinephrine/Adrenaline, 1 mg/ml, 1 ml
Actavis International, Luqa (MT)
Actavis International, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 1 mg/ml,1 ml
Actavis International, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 1 mg/ml, 4 ml
Actavis International, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 2 mg/ml, 1 ml
Actavis International, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin, 5K/1 ml, 5 ml
Actavis International, Luqa (MT)
Actavis International, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 50 mcg/ml 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 500 mcg/ml 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 20 mg/ml, 1 ml
Actavis International, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 50 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 60 mg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Amoxicillin sodium/Potassium clavulanate 1 g/100 mg/10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Levofloxacin 5 mg/ml/50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium 10 mg/ml, 25 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Mivacurium 2 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium 10 mg/1 ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine 100 mcg/ml 25 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Lorazepam 4 mg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam 5 mg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 30 mg/ml, 1ml
Actavis International, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol 10 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease - Dobutamine 50 mg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dobutamine 5 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dopamine 200 mg/1 ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Epinephrine/Adrenaline 1 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 80 mcg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 1 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin 25 IU/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin 100 IU/ ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 50 mcg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 100 mg/ml, 5 ml
Actavis International, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 2 mg/ml, 4 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 50 mcg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 5 mcg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 50 mcg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 2 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 10 ml
Actavis International, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Actavis International, Luqa (MT)
Actavis International, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg /ml 2 ml
Actavis International, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Actavis International, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexamethasone 4 mg/ml, 1 ml
Actavis International Limited, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Actavis International Limited, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Actavis International Limited, Luqa (MT)
Actavis International Limited, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 4 ml
Actavis International Limited, Luqa (MT)
Actavis International Limited, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 10 ml
Actavis International Limited, Luqa (MT)
Actavis International Limited, Luqa (MT)
Actavis International Limited, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 1 mg/ml, 5 ml
Actavis International Limited, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 3 ml
Actavis International Limited, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 50 ml
Actavis International Limited, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Actavis International Limited, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin, 5K/1 ml, 5 ml
Actavis International Limited, Luqa (MT)
Actavis International Limited, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 5 ml
Actavis International Limited, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Actavis International Limited, Luqa (MT)
Actavis International Limited, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 1 mg
Actavis International Limited, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 2 mg
Actavis International Limited, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 5 mg
Actavis International Limited, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Amoxicillin Sodium / Potassium Clavulanate 1 g/220 mg/10 ml
Actavis International Limited, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Azithromycin 500 mg/5 ml
Actavis International Limited, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 1 g/10 ml
Actavis International Limited, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl Citrate 50 mcg/ml, 2 ml
Actavis International Limited, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 1 g/10 ml
Actavis International Limited, Luqa (MT)
Actavis International Limited, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 2 g/10 ml
Actavis International Limited, Luqa (MT)
Actavis International Limited, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Levofloxacin, 5 mg/ml/100 ml
Actavis International Limited, Luqa (MT)
Actavis International Limited, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium, 10 mg/ml, 2,5 ml
Actavis International Limited, Luqa (MT)
Actavis International Limited, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Piperacillin and Tazobactam, 2 g and 0,25 g/50 ml
Actavis International Limited, Luqa (MT)
Actavis International Limited, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl Citrate 50 mcg/ml, 10 ml
Actavis International Limited, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Piperacillin and Tazobactam, 4 g and 0,5 g/100 ml
Actavis International Limited, Luqa (MT)
Actavis International Limited, Luqa (MT)
Actavis International Limited, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium, 10 mg/ml, 5 ml
Actavis International Limited, Luqa (MT)
Actavis International Limited, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 5 ml
Actavis International Limited, Luqa (MT)
Actavis International Limited, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 10 ml
Actavis International Limited, Luqa (MT)
Actavis International Limited, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Actavis International Limited, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 10 mg/ml, 1 ml
Actavis International Limited, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Actavis International Limited, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Actavis International Limited, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 4 ml
Actavis International Limited, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 10 ml
Actavis International Limited, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 1 mg/ml, 5 ml
Actavis International Limited, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 2 mg/ml, 50 ml
Actavis International Limited, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 1 ml
Actavis International Limited, Luqa (MT)
Actavis International Limited, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 3 ml
Actavis International Limited, Luqa (MT)
Actavis International Limited, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 10 mg/ml, 1 ml
Actavis International Limited, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 10 ml
Actavis International Limited, Luqa (MT)
Actavis International Limited, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 10 ml
Actavis International Limited, Luqa (MT)
Actavis International Limited, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 50 ml
Actavis International Limited, Luqa (MT)
Actavis International Limited, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 100 ml
Actavis International Limited, Luqa (MT)
Actavis International Limited, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 20 mg/ml, 50 ml
Actavis International Limited, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 20 mg/ml, 1 ml
Actavis International Limited, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dopamine, 40 mg/ml, 5 ml
Actavis International Limited, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Epinephrine/Adrenaline, 1 mg/ml, 1 ml
Actavis International Limited, Luqa (MT)
Actavis International Limited, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 1 mg/ml,1 ml
Actavis International Limited, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 1 mg/ml, 4 ml
Actavis International Limited, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 2 mg/ml, 1 ml
Actavis International Limited, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin, 5K/1 ml, 5 ml
Actavis International Limited, Luqa (MT)
Actavis International Limited, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 50 mcg/ml 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 500 mcg/ml 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 20 mg/ml, 1 ml
Actavis International Limited, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 50 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 60 mg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Amoxicillin sodium/Potassium clavulanate 1 g/100 mg/10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Levofloxacin 5 mg/ml/50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium 10 mg/ml, 25 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Mivacurium 2 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium 10 mg/1 ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine 100 mcg/ml 25 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Lorazepam 4 mg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam 5 mg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 30 mg/ml, 1ml
Actavis International Limited, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol 10 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease - Dobutamine 50 mg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dobutamine 5 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dopamine 200 mg/1 ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Epinephrine/Adrenaline 1 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 80 mcg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 1 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin 25 IU/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin 100 IU/ ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 50 mcg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 100 mg/ml, 5 ml
Actavis International Limited, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 2 mg/ml, 4 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 50 mcg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 5 mcg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 50 mcg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 2 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 10 ml
Actavis International Limited, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Actavis International Limited, Luqa (MT)
Actavis International Limited, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg /ml 2 ml
Actavis International Limited, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Actavis International Limited, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexamethasone 4 mg/ml, 1 ml
Actavis International Ltd, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Actavis International Ltd, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Actavis International Ltd, Luqa (MT)
Actavis International Ltd, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 4 ml
Actavis International Ltd, Luqa (MT)
Actavis International Ltd, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 10 ml
Actavis International Ltd, Luqa (MT)
Actavis International Ltd, Luqa (MT)
Actavis International Ltd, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 1 mg/ml, 5 ml
Actavis International Ltd, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 3 ml
Actavis International Ltd, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 50 ml
Actavis International Ltd, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Actavis International Ltd, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin, 5K/1 ml, 5 ml
Actavis International Ltd, Luqa (MT)
Actavis International Ltd, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 5 ml
Actavis International Ltd, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Actavis International Ltd, Luqa (MT)
Actavis International Ltd, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 1 mg
Actavis International Ltd, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 2 mg
Actavis International Ltd, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 5 mg
Actavis International Ltd, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Amoxicillin Sodium / Potassium Clavulanate 1 g/220 mg/10 ml
Actavis International Ltd, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Azithromycin 500 mg/5 ml
Actavis International Ltd, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 1 g/10 ml
Actavis International Ltd, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl Citrate 50 mcg/ml, 2 ml
Actavis International Ltd, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 1 g/10 ml
Actavis International Ltd, Luqa (MT)
Actavis International Ltd, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 2 g/10 ml
Actavis International Ltd, Luqa (MT)
Actavis International Ltd, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Levofloxacin, 5 mg/ml/100 ml
Actavis International Ltd, Luqa (MT)
Actavis International Ltd, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium, 10 mg/ml, 2,5 ml
Actavis International Ltd, Luqa (MT)
Actavis International Ltd, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Piperacillin and Tazobactam, 2 g and 0,25 g/50 ml
Actavis International Ltd, Luqa (MT)
Actavis International Ltd, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl Citrate 50 mcg/ml, 10 ml
Actavis International Ltd, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Piperacillin and Tazobactam, 4 g and 0,5 g/100 ml
Actavis International Ltd, Luqa (MT)
Actavis International Ltd, Luqa (MT)
Actavis International Ltd, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium, 10 mg/ml, 5 ml
Actavis International Ltd, Luqa (MT)
Actavis International Ltd, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 5 ml
Actavis International Ltd, Luqa (MT)
Actavis International Ltd, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 10 ml
Actavis International Ltd, Luqa (MT)
Actavis International Ltd, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Actavis International Ltd, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 10 mg/ml, 1 ml
Actavis International Ltd, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Actavis International Ltd, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Actavis International Ltd, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 4 ml
Actavis International Ltd, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 10 ml
Actavis International Ltd, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 1 mg/ml, 5 ml
Actavis International Ltd, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 2 mg/ml, 50 ml
Actavis International Ltd, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 1 ml
Actavis International Ltd, Luqa (MT)
Actavis International Ltd, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 3 ml
Actavis International Ltd, Luqa (MT)
Actavis International Ltd, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 10 mg/ml, 1 ml
Actavis International Ltd, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 10 ml
Actavis International Ltd, Luqa (MT)
Actavis International Ltd, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 10 ml
Actavis International Ltd, Luqa (MT)
Actavis International Ltd, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 50 ml
Actavis International Ltd, Luqa (MT)
Actavis International Ltd, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 100 ml
Actavis International Ltd, Luqa (MT)
Actavis International Ltd, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 20 mg/ml, 50 ml
Actavis International Ltd, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 20 mg/ml, 1 ml
Actavis International Ltd, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dopamine, 40 mg/ml, 5 ml
Actavis International Ltd, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Epinephrine/Adrenaline, 1 mg/ml, 1 ml
Actavis International Ltd, Luqa (MT)
Actavis International Ltd, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 1 mg/ml,1 ml
Actavis International Ltd, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 1 mg/ml, 4 ml
Actavis International Ltd, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 2 mg/ml, 1 ml
Actavis International Ltd, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin, 5K/1 ml, 5 ml
Actavis International Ltd, Luqa (MT)
Actavis International Ltd, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 50 mcg/ml 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 500 mcg/ml 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 20 mg/ml, 1 ml
Actavis International Ltd, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 50 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 60 mg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Amoxicillin sodium/Potassium clavulanate 1 g/100 mg/10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Levofloxacin 5 mg/ml/50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium 10 mg/ml, 25 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Mivacurium 2 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium 10 mg/1 ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine 100 mcg/ml 25 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Lorazepam 4 mg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam 5 mg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 30 mg/ml, 1ml
Actavis International Ltd, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol 10 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease - Dobutamine 50 mg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dobutamine 5 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dopamine 200 mg/1 ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Epinephrine/Adrenaline 1 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 80 mcg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 1 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin 25 IU/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin 100 IU/ ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 50 mcg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 100 mg/ml, 5 ml
Actavis International Ltd, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 2 mg/ml, 4 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 50 mcg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 5 mcg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 50 mcg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 2 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 10 ml
Actavis International Ltd, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Actavis International Ltd, Luqa (MT)
Actavis International Ltd, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg /ml 2 ml
Actavis International Ltd, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Actavis International Ltd, Luqa (MT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexamethasone 4 mg/ml, 1 ml
Akciju Sabiedriba "Kalceks", Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Akciju Sabiedriba "Kalceks", Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Akciju Sabiedriba "Kalceks", Riga (LV)
Akciju Sabiedriba "Kalceks", Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 4 ml
Akciju Sabiedriba "Kalceks", Riga (LV)
Akciju Sabiedriba "Kalceks", Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 10 ml
Akciju Sabiedriba "Kalceks", Riga (LV)
Akciju Sabiedriba "Kalceks", Riga (LV)
Akciju Sabiedriba "Kalceks", Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 1 mg/ml, 5 ml
Akciju Sabiedriba "Kalceks", Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 3 ml
Akciju Sabiedriba "Kalceks", Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 50 ml
Akciju Sabiedriba "Kalceks", Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Akciju Sabiedriba "Kalceks", Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin, 5K/1 ml, 5 ml
Akciju Sabiedriba "Kalceks", Riga (LV)
Akciju Sabiedriba "Kalceks", Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 5 ml
Akciju Sabiedriba "Kalceks", Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Akciju Sabiedriba "Kalceks", Riga (LV)
Akciju Sabiedriba "Kalceks", Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 1 mg
Akciju Sabiedriba "Kalceks", Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 2 mg
Akciju Sabiedriba "Kalceks", Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 5 mg
Akciju Sabiedriba "Kalceks", Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Amoxicillin Sodium / Potassium Clavulanate 1 g/220 mg/10 ml
Akciju Sabiedriba "Kalceks", Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Azithromycin 500 mg/5 ml
Akciju Sabiedriba "Kalceks", Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 1 g/10 ml
Akciju Sabiedriba "Kalceks", Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl Citrate 50 mcg/ml, 2 ml
Akciju Sabiedriba "Kalceks", Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 1 g/10 ml
Akciju Sabiedriba "Kalceks", Riga (LV)
Akciju Sabiedriba "Kalceks", Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 2 g/10 ml
Akciju Sabiedriba "Kalceks", Riga (LV)
Akciju Sabiedriba "Kalceks", Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Levofloxacin, 5 mg/ml/100 ml
Akciju Sabiedriba "Kalceks", Riga (LV)
Akciju Sabiedriba "Kalceks", Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium, 10 mg/ml, 2,5 ml
Akciju Sabiedriba "Kalceks", Riga (LV)
Akciju Sabiedriba "Kalceks", Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Piperacillin and Tazobactam, 2 g and 0,25 g/50 ml
Akciju Sabiedriba "Kalceks", Riga (LV)
Akciju Sabiedriba "Kalceks", Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl Citrate 50 mcg/ml, 10 ml
Akciju Sabiedriba "Kalceks", Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Piperacillin and Tazobactam, 4 g and 0,5 g/100 ml
Akciju Sabiedriba "Kalceks", Riga (LV)
Akciju Sabiedriba "Kalceks", Riga (LV)
Akciju Sabiedriba "Kalceks", Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium, 10 mg/ml, 5 ml
Akciju Sabiedriba "Kalceks", Riga (LV)
Akciju Sabiedriba "Kalceks", Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 5 ml
Akciju Sabiedriba "Kalceks", Riga (LV)
Akciju Sabiedriba "Kalceks", Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 10 ml
Akciju Sabiedriba "Kalceks", Riga (LV)
Akciju Sabiedriba "Kalceks", Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Akciju Sabiedriba "Kalceks", Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 10 mg/ml, 1 ml
Akciju Sabiedriba "Kalceks", Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Akciju Sabiedriba "Kalceks", Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Akciju Sabiedriba "Kalceks", Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 4 ml
Akciju Sabiedriba "Kalceks", Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 10 ml
Akciju Sabiedriba "Kalceks", Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 1 mg/ml, 5 ml
Akciju Sabiedriba "Kalceks", Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 2 mg/ml, 50 ml
Akciju Sabiedriba "Kalceks", Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 1 ml
Akciju Sabiedriba "Kalceks", Riga (LV)
Akciju Sabiedriba "Kalceks", Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 3 ml
Akciju Sabiedriba "Kalceks", Riga (LV)
Akciju Sabiedriba "Kalceks", Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 10 mg/ml, 1 ml
Akciju Sabiedriba "Kalceks", Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 10 ml
Akciju Sabiedriba "Kalceks", Riga (LV)
Akciju Sabiedriba "Kalceks", Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 10 ml
Akciju Sabiedriba "Kalceks", Riga (LV)
Akciju Sabiedriba "Kalceks", Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 50 ml
Akciju Sabiedriba "Kalceks", Riga (LV)
Akciju Sabiedriba "Kalceks", Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 100 ml
Akciju Sabiedriba "Kalceks", Riga (LV)
Akciju Sabiedriba "Kalceks", Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 20 mg/ml, 50 ml
Akciju Sabiedriba "Kalceks", Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 20 mg/ml, 1 ml
Akciju Sabiedriba "Kalceks", Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dopamine, 40 mg/ml, 5 ml
Akciju Sabiedriba "Kalceks", Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Epinephrine/Adrenaline, 1 mg/ml, 1 ml
Akciju Sabiedriba "Kalceks", Riga (LV)
Akciju Sabiedriba "Kalceks", Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 1 mg/ml,1 ml
Akciju Sabiedriba "Kalceks", Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 1 mg/ml, 4 ml
Akciju Sabiedriba "Kalceks", Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 2 mg/ml, 1 ml
Akciju Sabiedriba "Kalceks", Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin, 5K/1 ml, 5 ml
Akciju Sabiedriba "Kalceks", Riga (LV)
Akciju Sabiedriba "Kalceks", Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 50 mcg/ml 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 500 mcg/ml 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 20 mg/ml, 1 ml
Akciju Sabiedriba "Kalceks", Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 50 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 60 mg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Amoxicillin sodium/Potassium clavulanate 1 g/100 mg/10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Levofloxacin 5 mg/ml/50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium 10 mg/ml, 25 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Mivacurium 2 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium 10 mg/1 ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine 100 mcg/ml 25 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Lorazepam 4 mg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam 5 mg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 30 mg/ml, 1ml
Akciju Sabiedriba "Kalceks", Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol 10 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease - Dobutamine 50 mg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dobutamine 5 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dopamine 200 mg/1 ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Epinephrine/Adrenaline 1 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 80 mcg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 1 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin 25 IU/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin 100 IU/ ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 50 mcg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 100 mg/ml, 5 ml
Akciju Sabiedriba "Kalceks", Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 2 mg/ml, 4 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 50 mcg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 5 mcg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 50 mcg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 2 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 10 ml
Akciju Sabiedriba "Kalceks", Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Akciju Sabiedriba "Kalceks", Riga (LV)
Akciju Sabiedriba "Kalceks", Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg /ml 2 ml
Akciju Sabiedriba "Kalceks", Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Akciju Sabiedriba "Kalceks", Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexamethasone 4 mg/ml, 1 ml
Akciju Sabiedriba "Kalceks”, Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Akciju Sabiedriba "Kalceks”, Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Akciju Sabiedriba "Kalceks”, Riga (LV)
Akciju Sabiedriba "Kalceks”, Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 4 ml
Akciju Sabiedriba "Kalceks”, Riga (LV)
Akciju Sabiedriba "Kalceks”, Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 10 ml
Akciju Sabiedriba "Kalceks”, Riga (LV)
Akciju Sabiedriba "Kalceks”, Riga (LV)
Akciju Sabiedriba "Kalceks”, Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 1 mg/ml, 5 ml
Akciju Sabiedriba "Kalceks”, Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 3 ml
Akciju Sabiedriba "Kalceks”, Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 50 ml
Akciju Sabiedriba "Kalceks”, Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Akciju Sabiedriba "Kalceks”, Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin, 5K/1 ml, 5 ml
Akciju Sabiedriba "Kalceks”, Riga (LV)
Akciju Sabiedriba "Kalceks”, Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 5 ml
Akciju Sabiedriba "Kalceks”, Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Akciju Sabiedriba "Kalceks”, Riga (LV)
Akciju Sabiedriba "Kalceks”, Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 1 mg
Akciju Sabiedriba "Kalceks”, Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 2 mg
Akciju Sabiedriba "Kalceks”, Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 5 mg
Akciju Sabiedriba "Kalceks”, Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Amoxicillin Sodium / Potassium Clavulanate 1 g/220 mg/10 ml
Akciju Sabiedriba "Kalceks”, Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Azithromycin 500 mg/5 ml
Akciju Sabiedriba "Kalceks”, Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 1 g/10 ml
Akciju Sabiedriba "Kalceks”, Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl Citrate 50 mcg/ml, 2 ml
Akciju Sabiedriba "Kalceks”, Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 1 g/10 ml
Akciju Sabiedriba "Kalceks”, Riga (LV)
Akciju Sabiedriba "Kalceks”, Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 2 g/10 ml
Akciju Sabiedriba "Kalceks”, Riga (LV)
Akciju Sabiedriba "Kalceks”, Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Levofloxacin, 5 mg/ml/100 ml
Akciju Sabiedriba "Kalceks”, Riga (LV)
Akciju Sabiedriba "Kalceks”, Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium, 10 mg/ml, 2,5 ml
Akciju Sabiedriba "Kalceks”, Riga (LV)
Akciju Sabiedriba "Kalceks”, Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Piperacillin and Tazobactam, 2 g and 0,25 g/50 ml
Akciju Sabiedriba "Kalceks”, Riga (LV)
Akciju Sabiedriba "Kalceks”, Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl Citrate 50 mcg/ml, 10 ml
Akciju Sabiedriba "Kalceks”, Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Piperacillin and Tazobactam, 4 g and 0,5 g/100 ml
Akciju Sabiedriba "Kalceks”, Riga (LV)
Akciju Sabiedriba "Kalceks”, Riga (LV)
Akciju Sabiedriba "Kalceks”, Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium, 10 mg/ml, 5 ml
Akciju Sabiedriba "Kalceks”, Riga (LV)
Akciju Sabiedriba "Kalceks”, Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 5 ml
Akciju Sabiedriba "Kalceks”, Riga (LV)
Akciju Sabiedriba "Kalceks”, Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 10 ml
Akciju Sabiedriba "Kalceks”, Riga (LV)
Akciju Sabiedriba "Kalceks”, Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Akciju Sabiedriba "Kalceks”, Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 10 mg/ml, 1 ml
Akciju Sabiedriba "Kalceks”, Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Akciju Sabiedriba "Kalceks”, Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Akciju Sabiedriba "Kalceks”, Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 4 ml
Akciju Sabiedriba "Kalceks”, Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 10 ml
Akciju Sabiedriba "Kalceks”, Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 1 mg/ml, 5 ml
Akciju Sabiedriba "Kalceks”, Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 2 mg/ml, 50 ml
Akciju Sabiedriba "Kalceks”, Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 1 ml
Akciju Sabiedriba "Kalceks”, Riga (LV)
Akciju Sabiedriba "Kalceks”, Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 3 ml
Akciju Sabiedriba "Kalceks”, Riga (LV)
Akciju Sabiedriba "Kalceks”, Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 10 mg/ml, 1 ml
Akciju Sabiedriba "Kalceks”, Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 10 ml
Akciju Sabiedriba "Kalceks”, Riga (LV)
Akciju Sabiedriba "Kalceks”, Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 10 ml
Akciju Sabiedriba "Kalceks”, Riga (LV)
Akciju Sabiedriba "Kalceks”, Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 50 ml
Akciju Sabiedriba "Kalceks”, Riga (LV)
Akciju Sabiedriba "Kalceks”, Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 100 ml
Akciju Sabiedriba "Kalceks”, Riga (LV)
Akciju Sabiedriba "Kalceks”, Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 20 mg/ml, 50 ml
Akciju Sabiedriba "Kalceks”, Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 20 mg/ml, 1 ml
Akciju Sabiedriba "Kalceks”, Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dopamine, 40 mg/ml, 5 ml
Akciju Sabiedriba "Kalceks”, Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Epinephrine/Adrenaline, 1 mg/ml, 1 ml
Akciju Sabiedriba "Kalceks”, Riga (LV)
Akciju Sabiedriba "Kalceks”, Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 1 mg/ml,1 ml
Akciju Sabiedriba "Kalceks”, Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 1 mg/ml, 4 ml
Akciju Sabiedriba "Kalceks”, Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 2 mg/ml, 1 ml
Akciju Sabiedriba "Kalceks”, Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin, 5K/1 ml, 5 ml
Akciju Sabiedriba "Kalceks”, Riga (LV)
Akciju Sabiedriba "Kalceks”, Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 50 mcg/ml 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 500 mcg/ml 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 20 mg/ml, 1 ml
Akciju Sabiedriba "Kalceks”, Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 50 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 60 mg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Amoxicillin sodium/Potassium clavulanate 1 g/100 mg/10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Levofloxacin 5 mg/ml/50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium 10 mg/ml, 25 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Mivacurium 2 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium 10 mg/1 ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine 100 mcg/ml 25 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Lorazepam 4 mg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam 5 mg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 30 mg/ml, 1ml
Akciju Sabiedriba "Kalceks”, Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol 10 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease - Dobutamine 50 mg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dobutamine 5 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dopamine 200 mg/1 ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Epinephrine/Adrenaline 1 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 80 mcg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 1 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin 25 IU/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin 100 IU/ ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 50 mcg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 100 mg/ml, 5 ml
Akciju Sabiedriba "Kalceks”, Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 2 mg/ml, 4 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 50 mcg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 5 mcg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 50 mcg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 2 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 10 ml
Akciju Sabiedriba "Kalceks”, Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Akciju Sabiedriba "Kalceks”, Riga (LV)
Akciju Sabiedriba "Kalceks”, Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg /ml 2 ml
Akciju Sabiedriba "Kalceks”, Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Akciju Sabiedriba "Kalceks”, Riga (LV)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexamethasone 4 mg/ml, 1 ml
Antibiotice S.A., Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Antibiotice S.A., Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Antibiotice S.A., Iași (RO)
Antibiotice S.A., Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 4 ml
Antibiotice S.A., Iași (RO)
Antibiotice S.A., Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 10 ml
Antibiotice S.A., Iași (RO)
Antibiotice S.A., Iași (RO)
Antibiotice S.A., Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 1 mg/ml, 5 ml
Antibiotice S.A., Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 3 ml
Antibiotice S.A., Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 50 ml
Antibiotice S.A., Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Antibiotice S.A., Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin, 5K/1 ml, 5 ml
Antibiotice S.A., Iași (RO)
Antibiotice S.A., Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 5 ml
Antibiotice S.A., Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Antibiotice S.A., Iași (RO)
Antibiotice S.A., Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 1 mg
Antibiotice S.A., Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 2 mg
Antibiotice S.A., Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 5 mg
Antibiotice S.A., Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Amoxicillin Sodium / Potassium Clavulanate 1 g/220 mg/10 ml
Antibiotice S.A., Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Azithromycin 500 mg/5 ml
Antibiotice S.A., Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 1 g/10 ml
Antibiotice S.A., Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl Citrate 50 mcg/ml, 2 ml
Antibiotice S.A., Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 1 g/10 ml
Antibiotice S.A., Iași (RO)
Antibiotice S.A., Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 2 g/10 ml
Antibiotice S.A., Iași (RO)
Antibiotice S.A., Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Levofloxacin, 5 mg/ml/100 ml
Antibiotice S.A., Iași (RO)
Antibiotice S.A., Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium, 10 mg/ml, 2,5 ml
Antibiotice S.A., Iași (RO)
Antibiotice S.A., Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Piperacillin and Tazobactam, 2 g and 0,25 g/50 ml
Antibiotice S.A., Iași (RO)
Antibiotice S.A., Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl Citrate 50 mcg/ml, 10 ml
Antibiotice S.A., Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Piperacillin and Tazobactam, 4 g and 0,5 g/100 ml
Antibiotice S.A., Iași (RO)
Antibiotice S.A., Iași (RO)
Antibiotice S.A., Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium, 10 mg/ml, 5 ml
Antibiotice S.A., Iași (RO)
Antibiotice S.A., Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 5 ml
Antibiotice S.A., Iași (RO)
Antibiotice S.A., Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 10 ml
Antibiotice S.A., Iași (RO)
Antibiotice S.A., Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Antibiotice S.A., Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 10 mg/ml, 1 ml
Antibiotice S.A., Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Antibiotice S.A., Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Antibiotice S.A., Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 4 ml
Antibiotice S.A., Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 10 ml
Antibiotice S.A., Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 1 mg/ml, 5 ml
Antibiotice S.A., Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 2 mg/ml, 50 ml
Antibiotice S.A., Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 1 ml
Antibiotice S.A., Iași (RO)
Antibiotice S.A., Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 3 ml
Antibiotice S.A., Iași (RO)
Antibiotice S.A., Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 10 mg/ml, 1 ml
Antibiotice S.A., Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 10 ml
Antibiotice S.A., Iași (RO)
Antibiotice S.A., Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 10 ml
Antibiotice S.A., Iași (RO)
Antibiotice S.A., Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 50 ml
Antibiotice S.A., Iași (RO)
Antibiotice S.A., Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 100 ml
Antibiotice S.A., Iași (RO)
Antibiotice S.A., Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 20 mg/ml, 50 ml
Antibiotice S.A., Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 20 mg/ml, 1 ml
Antibiotice S.A., Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dopamine, 40 mg/ml, 5 ml
Antibiotice S.A., Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Epinephrine/Adrenaline, 1 mg/ml, 1 ml
Antibiotice S.A., Iași (RO)
Antibiotice S.A., Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 1 mg/ml,1 ml
Antibiotice S.A., Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 1 mg/ml, 4 ml
Antibiotice S.A., Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 2 mg/ml, 1 ml
Antibiotice S.A., Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin, 5K/1 ml, 5 ml
Antibiotice S.A., Iași (RO)
Antibiotice S.A., Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 50 mcg/ml 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 500 mcg/ml 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 20 mg/ml, 1 ml
Antibiotice S.A., Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 50 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 60 mg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Amoxicillin sodium/Potassium clavulanate 1 g/100 mg/10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Levofloxacin 5 mg/ml/50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium 10 mg/ml, 25 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Mivacurium 2 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium 10 mg/1 ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine 100 mcg/ml 25 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Lorazepam 4 mg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam 5 mg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 30 mg/ml, 1ml
Antibiotice S.A., Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol 10 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease - Dobutamine 50 mg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dobutamine 5 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dopamine 200 mg/1 ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Epinephrine/Adrenaline 1 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 80 mcg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 1 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin 25 IU/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin 100 IU/ ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 50 mcg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 100 mg/ml, 5 ml
Antibiotice S.A., Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 2 mg/ml, 4 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 50 mcg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 5 mcg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 50 mcg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 2 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 10 ml
Antibiotice S.A., Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Antibiotice S.A., Iași (RO)
Antibiotice S.A., Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg /ml 2 ml
Antibiotice S.A., Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Antibiotice S.A., Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexamethasone 4 mg/ml, 1 ml
Antibiotice SA, Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Antibiotice SA, Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Antibiotice SA, Iași (RO)
Antibiotice SA, Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 4 ml
Antibiotice SA, Iași (RO)
Antibiotice SA, Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 10 ml
Antibiotice SA, Iași (RO)
Antibiotice SA, Iași (RO)
Antibiotice SA, Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 1 mg/ml, 5 ml
Antibiotice SA, Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 3 ml
Antibiotice SA, Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 50 ml
Antibiotice SA, Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Antibiotice SA, Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin, 5K/1 ml, 5 ml
Antibiotice SA, Iași (RO)
Antibiotice SA, Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 5 ml
Antibiotice SA, Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Antibiotice SA, Iași (RO)
Antibiotice SA, Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 1 mg
Antibiotice SA, Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 2 mg
Antibiotice SA, Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 5 mg
Antibiotice SA, Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Amoxicillin Sodium / Potassium Clavulanate 1 g/220 mg/10 ml
Antibiotice SA, Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Azithromycin 500 mg/5 ml
Antibiotice SA, Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 1 g/10 ml
Antibiotice SA, Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl Citrate 50 mcg/ml, 2 ml
Antibiotice SA, Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 1 g/10 ml
Antibiotice SA, Iași (RO)
Antibiotice SA, Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 2 g/10 ml
Antibiotice SA, Iași (RO)
Antibiotice SA, Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Levofloxacin, 5 mg/ml/100 ml
Antibiotice SA, Iași (RO)
Antibiotice SA, Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium, 10 mg/ml, 2,5 ml
Antibiotice SA, Iași (RO)
Antibiotice SA, Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Piperacillin and Tazobactam, 2 g and 0,25 g/50 ml
Antibiotice SA, Iași (RO)
Antibiotice SA, Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl Citrate 50 mcg/ml, 10 ml
Antibiotice SA, Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Piperacillin and Tazobactam, 4 g and 0,5 g/100 ml
Antibiotice SA, Iași (RO)
Antibiotice SA, Iași (RO)
Antibiotice SA, Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium, 10 mg/ml, 5 ml
Antibiotice SA, Iași (RO)
Antibiotice SA, Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 5 ml
Antibiotice SA, Iași (RO)
Antibiotice SA, Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 10 ml
Antibiotice SA, Iași (RO)
Antibiotice SA, Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Antibiotice SA, Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 10 mg/ml, 1 ml
Antibiotice SA, Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Antibiotice SA, Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Antibiotice SA, Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 4 ml
Antibiotice SA, Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 10 ml
Antibiotice SA, Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 1 mg/ml, 5 ml
Antibiotice SA, Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 2 mg/ml, 50 ml
Antibiotice SA, Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 1 ml
Antibiotice SA, Iași (RO)
Antibiotice SA, Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 3 ml
Antibiotice SA, Iași (RO)
Antibiotice SA, Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 10 mg/ml, 1 ml
Antibiotice SA, Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 10 ml
Antibiotice SA, Iași (RO)
Antibiotice SA, Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 10 ml
Antibiotice SA, Iași (RO)
Antibiotice SA, Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 50 ml
Antibiotice SA, Iași (RO)
Antibiotice SA, Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 100 ml
Antibiotice SA, Iași (RO)
Antibiotice SA, Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 20 mg/ml, 50 ml
Antibiotice SA, Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 20 mg/ml, 1 ml
Antibiotice SA, Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dopamine, 40 mg/ml, 5 ml
Antibiotice SA, Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Epinephrine/Adrenaline, 1 mg/ml, 1 ml
Antibiotice SA, Iași (RO)
Antibiotice SA, Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 1 mg/ml,1 ml
Antibiotice SA, Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 1 mg/ml, 4 ml
Antibiotice SA, Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 2 mg/ml, 1 ml
Antibiotice SA, Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin, 5K/1 ml, 5 ml
Antibiotice SA, Iași (RO)
Antibiotice SA, Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 50 mcg/ml 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 500 mcg/ml 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 20 mg/ml, 1 ml
Antibiotice SA, Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 50 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 60 mg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Amoxicillin sodium/Potassium clavulanate 1 g/100 mg/10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Levofloxacin 5 mg/ml/50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium 10 mg/ml, 25 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Mivacurium 2 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium 10 mg/1 ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine 100 mcg/ml 25 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Lorazepam 4 mg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam 5 mg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 30 mg/ml, 1ml
Antibiotice SA, Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol 10 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease - Dobutamine 50 mg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dobutamine 5 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dopamine 200 mg/1 ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Epinephrine/Adrenaline 1 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 80 mcg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 1 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin 25 IU/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin 100 IU/ ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 50 mcg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 100 mg/ml, 5 ml
Antibiotice SA, Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 2 mg/ml, 4 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 50 mcg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 5 mcg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 50 mcg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 2 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 10 ml
Antibiotice SA, Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Antibiotice SA, Iași (RO)
Antibiotice SA, Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg /ml 2 ml
Antibiotice SA, Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Antibiotice SA, Iași (RO)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexamethasone 4 mg/ml, 1 ml
Aurobindo Pharma Italia, Saronno (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Aurobindo Pharma Italia, Saronno (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Aurobindo Pharma Italia, Saronno (IT)
Aurobindo Pharma Italia, Saronno (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 4 ml
Aurobindo Pharma Italia, Saronno (IT)
Aurobindo Pharma Italia, Saronno (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 10 ml
Aurobindo Pharma Italia, Saronno (IT)
Aurobindo Pharma Italia, Saronno (IT)
Aurobindo Pharma Italia, Saronno (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 1 mg/ml, 5 ml
Aurobindo Pharma Italia, Saronno (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 3 ml
Aurobindo Pharma Italia, Saronno (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 50 ml
Aurobindo Pharma Italia, Saronno (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Aurobindo Pharma Italia, Saronno (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin, 5K/1 ml, 5 ml
Aurobindo Pharma Italia, Saronno (IT)
Aurobindo Pharma Italia, Saronno (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 5 ml
Aurobindo Pharma Italia, Saronno (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Aurobindo Pharma Italia, Saronno (IT)
Aurobindo Pharma Italia, Saronno (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 1 mg
Aurobindo Pharma Italia, Saronno (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 2 mg
Aurobindo Pharma Italia, Saronno (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 5 mg
Aurobindo Pharma Italia, Saronno (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Amoxicillin Sodium / Potassium Clavulanate 1 g/220 mg/10 ml
Aurobindo Pharma Italia, Saronno (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Azithromycin 500 mg/5 ml
Aurobindo Pharma Italia, Saronno (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 1 g/10 ml
Aurobindo Pharma Italia, Saronno (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl Citrate 50 mcg/ml, 2 ml
Aurobindo Pharma Italia, Saronno (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 1 g/10 ml
Aurobindo Pharma Italia, Saronno (IT)
Aurobindo Pharma Italia, Saronno (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 2 g/10 ml
Aurobindo Pharma Italia, Saronno (IT)
Aurobindo Pharma Italia, Saronno (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Levofloxacin, 5 mg/ml/100 ml
Aurobindo Pharma Italia, Saronno (IT)
Aurobindo Pharma Italia, Saronno (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium, 10 mg/ml, 2,5 ml
Aurobindo Pharma Italia, Saronno (IT)
Aurobindo Pharma Italia, Saronno (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Piperacillin and Tazobactam, 2 g and 0,25 g/50 ml
Aurobindo Pharma Italia, Saronno (IT)
Aurobindo Pharma Italia, Saronno (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl Citrate 50 mcg/ml, 10 ml
Aurobindo Pharma Italia, Saronno (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Piperacillin and Tazobactam, 4 g and 0,5 g/100 ml
Aurobindo Pharma Italia, Saronno (IT)
Aurobindo Pharma Italia, Saronno (IT)
Aurobindo Pharma Italia, Saronno (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium, 10 mg/ml, 5 ml
Aurobindo Pharma Italia, Saronno (IT)
Aurobindo Pharma Italia, Saronno (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 5 ml
Aurobindo Pharma Italia, Saronno (IT)
Aurobindo Pharma Italia, Saronno (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 10 ml
Aurobindo Pharma Italia, Saronno (IT)
Aurobindo Pharma Italia, Saronno (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Aurobindo Pharma Italia, Saronno (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 10 mg/ml, 1 ml
Aurobindo Pharma Italia, Saronno (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Aurobindo Pharma Italia, Saronno (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Aurobindo Pharma Italia, Saronno (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 4 ml
Aurobindo Pharma Italia, Saronno (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 10 ml
Aurobindo Pharma Italia, Saronno (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 1 mg/ml, 5 ml
Aurobindo Pharma Italia, Saronno (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 2 mg/ml, 50 ml
Aurobindo Pharma Italia, Saronno (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 1 ml
Aurobindo Pharma Italia, Saronno (IT)
Aurobindo Pharma Italia, Saronno (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 3 ml
Aurobindo Pharma Italia, Saronno (IT)
Aurobindo Pharma Italia, Saronno (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 10 mg/ml, 1 ml
Aurobindo Pharma Italia, Saronno (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 10 ml
Aurobindo Pharma Italia, Saronno (IT)
Aurobindo Pharma Italia, Saronno (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 10 ml
Aurobindo Pharma Italia, Saronno (IT)
Aurobindo Pharma Italia, Saronno (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 50 ml
Aurobindo Pharma Italia, Saronno (IT)
Aurobindo Pharma Italia, Saronno (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 100 ml
Aurobindo Pharma Italia, Saronno (IT)
Aurobindo Pharma Italia, Saronno (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 20 mg/ml, 50 ml
Aurobindo Pharma Italia, Saronno (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 20 mg/ml, 1 ml
Aurobindo Pharma Italia, Saronno (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dopamine, 40 mg/ml, 5 ml
Aurobindo Pharma Italia, Saronno (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Epinephrine/Adrenaline, 1 mg/ml, 1 ml
Aurobindo Pharma Italia, Saronno (IT)
Aurobindo Pharma Italia, Saronno (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 1 mg/ml,1 ml
Aurobindo Pharma Italia, Saronno (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 1 mg/ml, 4 ml
Aurobindo Pharma Italia, Saronno (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 2 mg/ml, 1 ml
Aurobindo Pharma Italia, Saronno (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin, 5K/1 ml, 5 ml
Aurobindo Pharma Italia, Saronno (IT)
Aurobindo Pharma Italia, Saronno (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 50 mcg/ml 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 500 mcg/ml 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 20 mg/ml, 1 ml
Aurobindo Pharma Italia, Saronno (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 50 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 60 mg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Amoxicillin sodium/Potassium clavulanate 1 g/100 mg/10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Levofloxacin 5 mg/ml/50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium 10 mg/ml, 25 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Mivacurium 2 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium 10 mg/1 ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine 100 mcg/ml 25 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Lorazepam 4 mg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam 5 mg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 30 mg/ml, 1ml
Aurobindo Pharma Italia, Saronno (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol 10 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease - Dobutamine 50 mg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dobutamine 5 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dopamine 200 mg/1 ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Epinephrine/Adrenaline 1 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 80 mcg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 1 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin 25 IU/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin 100 IU/ ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 50 mcg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 100 mg/ml, 5 ml
Aurobindo Pharma Italia, Saronno (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 2 mg/ml, 4 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 50 mcg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 5 mcg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 50 mcg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 2 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 10 ml
Aurobindo Pharma Italia, Saronno (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Aurobindo Pharma Italia, Saronno (IT)
Aurobindo Pharma Italia, Saronno (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg /ml 2 ml
Aurobindo Pharma Italia, Saronno (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Aurobindo Pharma Italia, Saronno (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexamethasone 4 mg/ml, 1 ml
B. Braun Melsungen AG, Melsungen (DE)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
B. Braun Melsungen AG, Melsungen (DE)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
B. Braun Melsungen AG, Melsungen (DE)
B. Braun Melsungen AG, Melsungen (DE)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 4 ml
B. Braun Melsungen AG, Melsungen (DE)
B. Braun Melsungen AG, Melsungen (DE)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 10 ml
B. Braun Melsungen AG, Melsungen (DE)
B. Braun Melsungen AG, Melsungen (DE)
B. Braun Melsungen AG, Melsungen (DE)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 1 mg/ml, 5 ml
B. Braun Melsungen AG, Melsungen (DE)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 3 ml
B. Braun Melsungen AG, Melsungen (DE)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 50 ml
B. Braun Melsungen AG, Melsungen (DE)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
B. Braun Melsungen AG, Melsungen (DE)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin, 5K/1 ml, 5 ml
B. Braun Melsungen AG, Melsungen (DE)
B. Braun Melsungen AG, Melsungen (DE)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 5 ml
B. Braun Melsungen AG, Melsungen (DE)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
B. Braun Melsungen AG, Melsungen (DE)
B. Braun Melsungen AG, Melsungen (DE)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 1 mg
B. Braun Melsungen AG, Melsungen (DE)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 2 mg
B. Braun Melsungen AG, Melsungen (DE)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 5 mg
B. Braun Melsungen AG, Melsungen (DE)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Amoxicillin Sodium / Potassium Clavulanate 1 g/220 mg/10 ml
B. Braun Melsungen AG, Melsungen (DE)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Azithromycin 500 mg/5 ml
B. Braun Melsungen AG, Melsungen (DE)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 1 g/10 ml
B. Braun Melsungen AG, Melsungen (DE)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl Citrate 50 mcg/ml, 2 ml
B. Braun Melsungen AG, Melsungen (DE)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 1 g/10 ml
B. Braun Melsungen AG, Melsungen (DE)
B. Braun Melsungen AG, Melsungen (DE)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 2 g/10 ml
B. Braun Melsungen AG, Melsungen (DE)
B. Braun Melsungen AG, Melsungen (DE)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Levofloxacin, 5 mg/ml/100 ml
B. Braun Melsungen AG, Melsungen (DE)
B. Braun Melsungen AG, Melsungen (DE)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium, 10 mg/ml, 2,5 ml
B. Braun Melsungen AG, Melsungen (DE)
B. Braun Melsungen AG, Melsungen (DE)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Piperacillin and Tazobactam, 2 g and 0,25 g/50 ml
B. Braun Melsungen AG, Melsungen (DE)
B. Braun Melsungen AG, Melsungen (DE)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl Citrate 50 mcg/ml, 10 ml
B. Braun Melsungen AG, Melsungen (DE)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Piperacillin and Tazobactam, 4 g and 0,5 g/100 ml
B. Braun Melsungen AG, Melsungen (DE)
B. Braun Melsungen AG, Melsungen (DE)
B. Braun Melsungen AG, Melsungen (DE)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium, 10 mg/ml, 5 ml
B. Braun Melsungen AG, Melsungen (DE)
B. Braun Melsungen AG, Melsungen (DE)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 5 ml
B. Braun Melsungen AG, Melsungen (DE)
B. Braun Melsungen AG, Melsungen (DE)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 10 ml
B. Braun Melsungen AG, Melsungen (DE)
B. Braun Melsungen AG, Melsungen (DE)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
B. Braun Melsungen AG, Melsungen (DE)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 10 mg/ml, 1 ml
B. Braun Melsungen AG, Melsungen (DE)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
B. Braun Melsungen AG, Melsungen (DE)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
B. Braun Melsungen AG, Melsungen (DE)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 4 ml
B. Braun Melsungen AG, Melsungen (DE)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 10 ml
B. Braun Melsungen AG, Melsungen (DE)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 1 mg/ml, 5 ml
B. Braun Melsungen AG, Melsungen (DE)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 2 mg/ml, 50 ml
B. Braun Melsungen AG, Melsungen (DE)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 1 ml
B. Braun Melsungen AG, Melsungen (DE)
B. Braun Melsungen AG, Melsungen (DE)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 3 ml
B. Braun Melsungen AG, Melsungen (DE)
B. Braun Melsungen AG, Melsungen (DE)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 10 mg/ml, 1 ml
B. Braun Melsungen AG, Melsungen (DE)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 10 ml
B. Braun Melsungen AG, Melsungen (DE)
B. Braun Melsungen AG, Melsungen (DE)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 10 ml
B. Braun Melsungen AG, Melsungen (DE)
B. Braun Melsungen AG, Melsungen (DE)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 50 ml
B. Braun Melsungen AG, Melsungen (DE)
B. Braun Melsungen AG, Melsungen (DE)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 100 ml
B. Braun Melsungen AG, Melsungen (DE)
B. Braun Melsungen AG, Melsungen (DE)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 20 mg/ml, 50 ml
B. Braun Melsungen AG, Melsungen (DE)
B. Braun Melsungen AG, Melsungen (DE)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 20 mg/ml, 1 ml
B. Braun Melsungen AG, Melsungen (DE)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dopamine, 40 mg/ml, 5 ml
B. Braun Melsungen AG, Melsungen (DE)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Epinephrine/Adrenaline, 1 mg/ml, 1 ml
B. Braun Melsungen AG, Melsungen (DE)
B. Braun Melsungen AG, Melsungen (DE)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 1 mg/ml,1 ml
B. Braun Melsungen AG, Melsungen (DE)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 1 mg/ml, 4 ml
B. Braun Melsungen AG, Melsungen (DE)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 2 mg/ml, 1 ml
B. Braun Melsungen AG, Melsungen (DE)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin, 5K/1 ml, 5 ml
B. Braun Melsungen AG, Melsungen (DE)
B. Braun Melsungen AG, Melsungen (DE)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 50 mcg/ml 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 500 mcg/ml 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 20 mg/ml, 1 ml
B. Braun Melsungen AG, Melsungen (DE)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 50 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 60 mg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Amoxicillin sodium/Potassium clavulanate 1 g/100 mg/10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Levofloxacin 5 mg/ml/50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium 10 mg/ml, 25 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Mivacurium 2 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium 10 mg/1 ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine 100 mcg/ml 25 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Lorazepam 4 mg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam 5 mg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 30 mg/ml, 1ml
B. Braun Melsungen AG, Melsungen (DE)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol 10 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease - Dobutamine 50 mg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dobutamine 5 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dopamine 200 mg/1 ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Epinephrine/Adrenaline 1 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 80 mcg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 1 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin 25 IU/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin 100 IU/ ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 50 mcg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 100 mg/ml, 5 ml
B. Braun Melsungen AG, Melsungen (DE)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 2 mg/ml, 4 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 50 mcg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 5 mcg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 50 mcg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 2 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 10 ml
B. Braun Melsungen AG, Melsungen (DE)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
B. Braun Melsungen AG, Melsungen (DE)
B. Braun Melsungen AG, Melsungen (DE)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg /ml 2 ml
B. Braun Melsungen AG, Melsungen (DE)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
B. Braun Melsungen AG, Melsungen (DE)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexamethasone 4 mg/ml, 1 ml
Baxter Healthcare, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Baxter Healthcare, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Baxter Healthcare, Norfolk (UK)
Baxter Healthcare, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 4 ml
Baxter Healthcare, Norfolk (UK)
Baxter Healthcare, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 10 ml
Baxter Healthcare, Norfolk (UK)
Baxter Healthcare, Norfolk (UK)
Baxter Healthcare, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 1 mg/ml, 5 ml
Baxter Healthcare, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 3 ml
Baxter Healthcare, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 50 ml
Baxter Healthcare, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Baxter Healthcare, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin, 5K/1 ml, 5 ml
Baxter Healthcare, Norfolk (UK)
Baxter Healthcare, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 5 ml
Baxter Healthcare, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Baxter Healthcare, Norfolk (UK)
Baxter Healthcare, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 1 mg
Baxter Healthcare, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 2 mg
Baxter Healthcare, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 5 mg
Baxter Healthcare, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Amoxicillin Sodium / Potassium Clavulanate 1 g/220 mg/10 ml
Baxter Healthcare, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Azithromycin 500 mg/5 ml
Baxter Healthcare, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 1 g/10 ml
Baxter Healthcare, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl Citrate 50 mcg/ml, 2 ml
Baxter Healthcare, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 1 g/10 ml
Baxter Healthcare, Norfolk (UK)
Baxter Healthcare, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 2 g/10 ml
Baxter Healthcare, Norfolk (UK)
Baxter Healthcare, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Levofloxacin, 5 mg/ml/100 ml
Baxter Healthcare, Norfolk (UK)
Baxter Healthcare, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium, 10 mg/ml, 2,5 ml
Baxter Healthcare, Norfolk (UK)
Baxter Healthcare, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Piperacillin and Tazobactam, 2 g and 0,25 g/50 ml
Baxter Healthcare, Norfolk (UK)
Baxter Healthcare, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl Citrate 50 mcg/ml, 10 ml
Baxter Healthcare, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Piperacillin and Tazobactam, 4 g and 0,5 g/100 ml
Baxter Healthcare, Norfolk (UK)
Baxter Healthcare, Norfolk (UK)
Baxter Healthcare, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium, 10 mg/ml, 5 ml
Baxter Healthcare, Norfolk (UK)
Baxter Healthcare, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 5 ml
Baxter Healthcare, Norfolk (UK)
Baxter Healthcare, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 10 ml
Baxter Healthcare, Norfolk (UK)
Baxter Healthcare, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Baxter Healthcare, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 10 mg/ml, 1 ml
Baxter Healthcare, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Baxter Healthcare, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Baxter Healthcare, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 4 ml
Baxter Healthcare, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 10 ml
Baxter Healthcare, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 1 mg/ml, 5 ml
Baxter Healthcare, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 2 mg/ml, 50 ml
Baxter Healthcare, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 1 ml
Baxter Healthcare, Norfolk (UK)
Baxter Healthcare, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 3 ml
Baxter Healthcare, Norfolk (UK)
Baxter Healthcare, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 10 mg/ml, 1 ml
Baxter Healthcare, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 10 ml
Baxter Healthcare, Norfolk (UK)
Baxter Healthcare, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 10 ml
Baxter Healthcare, Norfolk (UK)
Baxter Healthcare, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 50 ml
Baxter Healthcare, Norfolk (UK)
Baxter Healthcare, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 100 ml
Baxter Healthcare, Norfolk (UK)
Baxter Healthcare, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 20 mg/ml, 50 ml
Baxter Healthcare, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 20 mg/ml, 1 ml
Baxter Healthcare, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dopamine, 40 mg/ml, 5 ml
Baxter Healthcare, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Epinephrine/Adrenaline, 1 mg/ml, 1 ml
Baxter Healthcare, Norfolk (UK)
Baxter Healthcare, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 1 mg/ml,1 ml
Baxter Healthcare, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 1 mg/ml, 4 ml
Baxter Healthcare, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 2 mg/ml, 1 ml
Baxter Healthcare, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin, 5K/1 ml, 5 ml
Baxter Healthcare, Norfolk (UK)
Baxter Healthcare, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 50 mcg/ml 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 500 mcg/ml 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 20 mg/ml, 1 ml
Baxter Healthcare, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 50 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 60 mg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Amoxicillin sodium/Potassium clavulanate 1 g/100 mg/10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Levofloxacin 5 mg/ml/50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium 10 mg/ml, 25 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Mivacurium 2 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium 10 mg/1 ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine 100 mcg/ml 25 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Lorazepam 4 mg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam 5 mg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 30 mg/ml, 1ml
Baxter Healthcare, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol 10 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease - Dobutamine 50 mg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dobutamine 5 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dopamine 200 mg/1 ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Epinephrine/Adrenaline 1 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 80 mcg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 1 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin 25 IU/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin 100 IU/ ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 50 mcg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 100 mg/ml, 5 ml
Baxter Healthcare, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 2 mg/ml, 4 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 50 mcg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 5 mcg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 50 mcg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 2 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 10 ml
Baxter Healthcare, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Baxter Healthcare, Norfolk (UK)
Baxter Healthcare, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg /ml 2 ml
Baxter Healthcare, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Baxter Healthcare, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexamethasone 4 mg/ml, 1 ml
Baxter Healthcare Ltd, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Baxter Healthcare Ltd, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Baxter Healthcare Ltd, Norfolk (UK)
Baxter Healthcare Ltd, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 4 ml
Baxter Healthcare Ltd, Norfolk (UK)
Baxter Healthcare Ltd, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 10 ml
Baxter Healthcare Ltd, Norfolk (UK)
Baxter Healthcare Ltd, Norfolk (UK)
Baxter Healthcare Ltd, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 1 mg/ml, 5 ml
Baxter Healthcare Ltd, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 3 ml
Baxter Healthcare Ltd, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 50 ml
Baxter Healthcare Ltd, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Baxter Healthcare Ltd, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin, 5K/1 ml, 5 ml
Baxter Healthcare Ltd, Norfolk (UK)
Baxter Healthcare Ltd, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 5 ml
Baxter Healthcare Ltd, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Baxter Healthcare Ltd, Norfolk (UK)
Baxter Healthcare Ltd, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 1 mg
Baxter Healthcare Ltd, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 2 mg
Baxter Healthcare Ltd, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 5 mg
Baxter Healthcare Ltd, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Amoxicillin Sodium / Potassium Clavulanate 1 g/220 mg/10 ml
Baxter Healthcare Ltd, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Azithromycin 500 mg/5 ml
Baxter Healthcare Ltd, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 1 g/10 ml
Baxter Healthcare Ltd, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl Citrate 50 mcg/ml, 2 ml
Baxter Healthcare Ltd, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 1 g/10 ml
Baxter Healthcare Ltd, Norfolk (UK)
Baxter Healthcare Ltd, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 2 g/10 ml
Baxter Healthcare Ltd, Norfolk (UK)
Baxter Healthcare Ltd, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Levofloxacin, 5 mg/ml/100 ml
Baxter Healthcare Ltd, Norfolk (UK)
Baxter Healthcare Ltd, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium, 10 mg/ml, 2,5 ml
Baxter Healthcare Ltd, Norfolk (UK)
Baxter Healthcare Ltd, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Piperacillin and Tazobactam, 2 g and 0,25 g/50 ml
Baxter Healthcare Ltd, Norfolk (UK)
Baxter Healthcare Ltd, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl Citrate 50 mcg/ml, 10 ml
Baxter Healthcare Ltd, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Piperacillin and Tazobactam, 4 g and 0,5 g/100 ml
Baxter Healthcare Ltd, Norfolk (UK)
Baxter Healthcare Ltd, Norfolk (UK)
Baxter Healthcare Ltd, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium, 10 mg/ml, 5 ml
Baxter Healthcare Ltd, Norfolk (UK)
Baxter Healthcare Ltd, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 5 ml
Baxter Healthcare Ltd, Norfolk (UK)
Baxter Healthcare Ltd, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 10 ml
Baxter Healthcare Ltd, Norfolk (UK)
Baxter Healthcare Ltd, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Baxter Healthcare Ltd, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 10 mg/ml, 1 ml
Baxter Healthcare Ltd, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Baxter Healthcare Ltd, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Baxter Healthcare Ltd, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 4 ml
Baxter Healthcare Ltd, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 10 ml
Baxter Healthcare Ltd, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 1 mg/ml, 5 ml
Baxter Healthcare Ltd, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 2 mg/ml, 50 ml
Baxter Healthcare Ltd, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 1 ml
Baxter Healthcare Ltd, Norfolk (UK)
Baxter Healthcare Ltd, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 3 ml
Baxter Healthcare Ltd, Norfolk (UK)
Baxter Healthcare Ltd, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 10 mg/ml, 1 ml
Baxter Healthcare Ltd, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 10 ml
Baxter Healthcare Ltd, Norfolk (UK)
Baxter Healthcare Ltd, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 10 ml
Baxter Healthcare Ltd, Norfolk (UK)
Baxter Healthcare Ltd, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 50 ml
Baxter Healthcare Ltd, Norfolk (UK)
Baxter Healthcare Ltd, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 100 ml
Baxter Healthcare Ltd, Norfolk (UK)
Baxter Healthcare Ltd, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 20 mg/ml, 50 ml
Baxter Healthcare Ltd, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 20 mg/ml, 1 ml
Baxter Healthcare Ltd, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dopamine, 40 mg/ml, 5 ml
Baxter Healthcare Ltd, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Epinephrine/Adrenaline, 1 mg/ml, 1 ml
Baxter Healthcare Ltd, Norfolk (UK)
Baxter Healthcare Ltd, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 1 mg/ml,1 ml
Baxter Healthcare Ltd, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 1 mg/ml, 4 ml
Baxter Healthcare Ltd, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 2 mg/ml, 1 ml
Baxter Healthcare Ltd, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin, 5K/1 ml, 5 ml
Baxter Healthcare Ltd, Norfolk (UK)
Baxter Healthcare Ltd, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 50 mcg/ml 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 500 mcg/ml 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 20 mg/ml, 1 ml
Baxter Healthcare Ltd, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 50 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 60 mg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Amoxicillin sodium/Potassium clavulanate 1 g/100 mg/10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Levofloxacin 5 mg/ml/50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium 10 mg/ml, 25 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Mivacurium 2 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium 10 mg/1 ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine 100 mcg/ml 25 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Lorazepam 4 mg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam 5 mg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 30 mg/ml, 1ml
Baxter Healthcare Ltd, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol 10 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease - Dobutamine 50 mg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dobutamine 5 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dopamine 200 mg/1 ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Epinephrine/Adrenaline 1 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 80 mcg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 1 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin 25 IU/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin 100 IU/ ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 50 mcg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 100 mg/ml, 5 ml
Baxter Healthcare Ltd, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 2 mg/ml, 4 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 50 mcg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 5 mcg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 50 mcg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 2 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 10 ml
Baxter Healthcare Ltd, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Baxter Healthcare Ltd, Norfolk (UK)
Baxter Healthcare Ltd, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg /ml 2 ml
Baxter Healthcare Ltd, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Baxter Healthcare Ltd, Norfolk (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexamethasone 4 mg/ml, 1 ml
Demo S.A, Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Demo S.A, Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Demo S.A, Attiki (GR)
Demo S.A, Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 4 ml
Demo S.A, Attiki (GR)
Demo S.A, Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 10 ml
Demo S.A, Attiki (GR)
Demo S.A, Attiki (GR)
Demo S.A, Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 1 mg/ml, 5 ml
Demo S.A, Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 3 ml
Demo S.A, Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 50 ml
Demo S.A, Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Demo S.A, Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin, 5K/1 ml, 5 ml
Demo S.A, Attiki (GR)
Demo S.A, Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 5 ml
Demo S.A, Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Demo S.A, Attiki (GR)
Demo S.A, Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 1 mg
Demo S.A, Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 2 mg
Demo S.A, Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 5 mg
Demo S.A, Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Amoxicillin Sodium / Potassium Clavulanate 1 g/220 mg/10 ml
Demo S.A, Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Azithromycin 500 mg/5 ml
Demo S.A, Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 1 g/10 ml
Demo S.A, Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl Citrate 50 mcg/ml, 2 ml
Demo S.A, Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 1 g/10 ml
Demo S.A, Attiki (GR)
Demo S.A, Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 2 g/10 ml
Demo S.A, Attiki (GR)
Demo S.A, Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Levofloxacin, 5 mg/ml/100 ml
Demo S.A, Attiki (GR)
Demo S.A, Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium, 10 mg/ml, 2,5 ml
Demo S.A, Attiki (GR)
Demo S.A, Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Piperacillin and Tazobactam, 2 g and 0,25 g/50 ml
Demo S.A, Attiki (GR)
Demo S.A, Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl Citrate 50 mcg/ml, 10 ml
Demo S.A, Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Piperacillin and Tazobactam, 4 g and 0,5 g/100 ml
Demo S.A, Attiki (GR)
Demo S.A, Attiki (GR)
Demo S.A, Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium, 10 mg/ml, 5 ml
Demo S.A, Attiki (GR)
Demo S.A, Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 5 ml
Demo S.A, Attiki (GR)
Demo S.A, Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 10 ml
Demo S.A, Attiki (GR)
Demo S.A, Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Demo S.A, Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 10 mg/ml, 1 ml
Demo S.A, Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Demo S.A, Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Demo S.A, Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 4 ml
Demo S.A, Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 10 ml
Demo S.A, Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 1 mg/ml, 5 ml
Demo S.A, Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 2 mg/ml, 50 ml
Demo S.A, Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 1 ml
Demo S.A, Attiki (GR)
Demo S.A, Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 3 ml
Demo S.A, Attiki (GR)
Demo S.A, Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 10 mg/ml, 1 ml
Demo S.A, Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 10 ml
Demo S.A, Attiki (GR)
Demo S.A, Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 10 ml
Demo S.A, Attiki (GR)
Demo S.A, Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 50 ml
Demo S.A, Attiki (GR)
Demo S.A, Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 100 ml
Demo S.A, Attiki (GR)
Demo S.A, Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 20 mg/ml, 50 ml
Demo S.A, Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 20 mg/ml, 1 ml
Demo S.A, Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dopamine, 40 mg/ml, 5 ml
Demo S.A, Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Epinephrine/Adrenaline, 1 mg/ml, 1 ml
Demo S.A, Attiki (GR)
Demo S.A, Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 1 mg/ml,1 ml
Demo S.A, Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 1 mg/ml, 4 ml
Demo S.A, Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 2 mg/ml, 1 ml
Demo S.A, Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin, 5K/1 ml, 5 ml
Demo S.A, Attiki (GR)
Demo S.A, Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 50 mcg/ml 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 500 mcg/ml 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 20 mg/ml, 1 ml
Demo S.A, Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 50 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 60 mg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Amoxicillin sodium/Potassium clavulanate 1 g/100 mg/10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Levofloxacin 5 mg/ml/50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium 10 mg/ml, 25 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Mivacurium 2 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium 10 mg/1 ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine 100 mcg/ml 25 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Lorazepam 4 mg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam 5 mg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 30 mg/ml, 1ml
Demo S.A, Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol 10 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease - Dobutamine 50 mg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dobutamine 5 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dopamine 200 mg/1 ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Epinephrine/Adrenaline 1 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 80 mcg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 1 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin 25 IU/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin 100 IU/ ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 50 mcg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 100 mg/ml, 5 ml
Demo S.A, Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 2 mg/ml, 4 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 50 mcg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 5 mcg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 50 mcg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 2 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 10 ml
Demo S.A, Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Demo S.A, Attiki (GR)
Demo S.A, Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg /ml 2 ml
Demo S.A, Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Demo S.A, Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexamethasone 4 mg/ml, 1 ml
Demo S.A., Krioneri Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Demo S.A., Krioneri Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Demo S.A., Krioneri Attiki (GR)
Demo S.A., Krioneri Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 4 ml
Demo S.A., Krioneri Attiki (GR)
Demo S.A., Krioneri Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 10 ml
Demo S.A., Krioneri Attiki (GR)
Demo S.A., Krioneri Attiki (GR)
Demo S.A., Krioneri Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 1 mg/ml, 5 ml
Demo S.A., Krioneri Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 3 ml
Demo S.A., Krioneri Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 50 ml
Demo S.A., Krioneri Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Demo S.A., Krioneri Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin, 5K/1 ml, 5 ml
Demo S.A., Krioneri Attiki (GR)
Demo S.A., Krioneri Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 5 ml
Demo S.A., Krioneri Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Demo S.A., Krioneri Attiki (GR)
Demo S.A., Krioneri Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 1 mg
Demo S.A., Krioneri Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 2 mg
Demo S.A., Krioneri Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 5 mg
Demo S.A., Krioneri Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Amoxicillin Sodium / Potassium Clavulanate 1 g/220 mg/10 ml
Demo S.A., Krioneri Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Azithromycin 500 mg/5 ml
Demo S.A., Krioneri Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 1 g/10 ml
Demo S.A., Krioneri Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl Citrate 50 mcg/ml, 2 ml
Demo S.A., Krioneri Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 1 g/10 ml
Demo S.A., Krioneri Attiki (GR)
Demo S.A., Krioneri Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 2 g/10 ml
Demo S.A., Krioneri Attiki (GR)
Demo S.A., Krioneri Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Levofloxacin, 5 mg/ml/100 ml
Demo S.A., Krioneri Attiki (GR)
Demo S.A., Krioneri Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium, 10 mg/ml, 2,5 ml
Demo S.A., Krioneri Attiki (GR)
Demo S.A., Krioneri Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Piperacillin and Tazobactam, 2 g and 0,25 g/50 ml
Demo S.A., Krioneri Attiki (GR)
Demo S.A., Krioneri Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl Citrate 50 mcg/ml, 10 ml
Demo S.A., Krioneri Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Piperacillin and Tazobactam, 4 g and 0,5 g/100 ml
Demo S.A., Krioneri Attiki (GR)
Demo S.A., Krioneri Attiki (GR)
Demo S.A., Krioneri Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium, 10 mg/ml, 5 ml
Demo S.A., Krioneri Attiki (GR)
Demo S.A., Krioneri Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 5 ml
Demo S.A., Krioneri Attiki (GR)
Demo S.A., Krioneri Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 10 ml
Demo S.A., Krioneri Attiki (GR)
Demo S.A., Krioneri Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Demo S.A., Krioneri Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 10 mg/ml, 1 ml
Demo S.A., Krioneri Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Demo S.A., Krioneri Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Demo S.A., Krioneri Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 4 ml
Demo S.A., Krioneri Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 10 ml
Demo S.A., Krioneri Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 1 mg/ml, 5 ml
Demo S.A., Krioneri Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 2 mg/ml, 50 ml
Demo S.A., Krioneri Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 1 ml
Demo S.A., Krioneri Attiki (GR)
Demo S.A., Krioneri Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 3 ml
Demo S.A., Krioneri Attiki (GR)
Demo S.A., Krioneri Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 10 mg/ml, 1 ml
Demo S.A., Krioneri Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 10 ml
Demo S.A., Krioneri Attiki (GR)
Demo S.A., Krioneri Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 10 ml
Demo S.A., Krioneri Attiki (GR)
Demo S.A., Krioneri Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 50 ml
Demo S.A., Krioneri Attiki (GR)
Demo S.A., Krioneri Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 100 ml
Demo S.A., Krioneri Attiki (GR)
Demo S.A., Krioneri Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 20 mg/ml, 50 ml
Demo S.A., Krioneri Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 20 mg/ml, 1 ml
Demo S.A., Krioneri Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dopamine, 40 mg/ml, 5 ml
Demo S.A., Krioneri Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Epinephrine/Adrenaline, 1 mg/ml, 1 ml
Demo S.A., Krioneri Attiki (GR)
Demo S.A., Krioneri Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 1 mg/ml,1 ml
Demo S.A., Krioneri Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 1 mg/ml, 4 ml
Demo S.A., Krioneri Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 2 mg/ml, 1 ml
Demo S.A., Krioneri Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin, 5K/1 ml, 5 ml
Demo S.A., Krioneri Attiki (GR)
Demo S.A., Krioneri Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 50 mcg/ml 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 500 mcg/ml 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 20 mg/ml, 1 ml
Demo S.A., Krioneri Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 50 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 60 mg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Amoxicillin sodium/Potassium clavulanate 1 g/100 mg/10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Levofloxacin 5 mg/ml/50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium 10 mg/ml, 25 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Mivacurium 2 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium 10 mg/1 ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine 100 mcg/ml 25 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Lorazepam 4 mg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam 5 mg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 30 mg/ml, 1ml
Demo S.A., Krioneri Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol 10 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease - Dobutamine 50 mg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dobutamine 5 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dopamine 200 mg/1 ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Epinephrine/Adrenaline 1 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 80 mcg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 1 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin 25 IU/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin 100 IU/ ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 50 mcg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 100 mg/ml, 5 ml
Demo S.A., Krioneri Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 2 mg/ml, 4 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 50 mcg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 5 mcg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 50 mcg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 2 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 10 ml
Demo S.A., Krioneri Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Demo S.A., Krioneri Attiki (GR)
Demo S.A., Krioneri Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg /ml 2 ml
Demo S.A., Krioneri Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Demo S.A., Krioneri Attiki (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexamethasone 4 mg/ml, 1 ml
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 4 ml
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 10 ml
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 1 mg/ml, 5 ml
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 3 ml
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 50 ml
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin, 5K/1 ml, 5 ml
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 5 ml
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 1 mg
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 2 mg
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 5 mg
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Amoxicillin Sodium / Potassium Clavulanate 1 g/220 mg/10 ml
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Azithromycin 500 mg/5 ml
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 1 g/10 ml
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl Citrate 50 mcg/ml, 2 ml
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 1 g/10 ml
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 2 g/10 ml
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Levofloxacin, 5 mg/ml/100 ml
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium, 10 mg/ml, 2,5 ml
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Piperacillin and Tazobactam, 2 g and 0,25 g/50 ml
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl Citrate 50 mcg/ml, 10 ml
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Piperacillin and Tazobactam, 4 g and 0,5 g/100 ml
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium, 10 mg/ml, 5 ml
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 5 ml
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 10 ml
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 10 mg/ml, 1 ml
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 4 ml
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 10 ml
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 1 mg/ml, 5 ml
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 2 mg/ml, 50 ml
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 1 ml
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 3 ml
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 10 mg/ml, 1 ml
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 10 ml
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 10 ml
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 50 ml
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 100 ml
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 20 mg/ml, 50 ml
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 20 mg/ml, 1 ml
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dopamine, 40 mg/ml, 5 ml
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Epinephrine/Adrenaline, 1 mg/ml, 1 ml
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 1 mg/ml,1 ml
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 1 mg/ml, 4 ml
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 2 mg/ml, 1 ml
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin, 5K/1 ml, 5 ml
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 50 mcg/ml 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 500 mcg/ml 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 20 mg/ml, 1 ml
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 50 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 60 mg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Amoxicillin sodium/Potassium clavulanate 1 g/100 mg/10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Levofloxacin 5 mg/ml/50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium 10 mg/ml, 25 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Mivacurium 2 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium 10 mg/1 ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine 100 mcg/ml 25 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Lorazepam 4 mg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam 5 mg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 30 mg/ml, 1ml
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol 10 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease - Dobutamine 50 mg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dobutamine 5 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dopamine 200 mg/1 ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Epinephrine/Adrenaline 1 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 80 mcg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 1 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin 25 IU/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin 100 IU/ ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 50 mcg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 100 mg/ml, 5 ml
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 2 mg/ml, 4 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 50 mcg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 5 mcg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 50 mcg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 2 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 10 ml
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg /ml 2 ml
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Demo S.A. Pharmaceutical Industry, Krioneri (GR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexamethasone 4 mg/ml, 1 ml
D-R Panovski, Skopje (MK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
D-R Panovski, Skopje (MK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
D-R Panovski, Skopje (MK)
D-R Panovski, Skopje (MK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 4 ml
D-R Panovski, Skopje (MK)
D-R Panovski, Skopje (MK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 10 ml
D-R Panovski, Skopje (MK)
D-R Panovski, Skopje (MK)
D-R Panovski, Skopje (MK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 1 mg/ml, 5 ml
D-R Panovski, Skopje (MK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 3 ml
D-R Panovski, Skopje (MK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 50 ml
D-R Panovski, Skopje (MK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
D-R Panovski, Skopje (MK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin, 5K/1 ml, 5 ml
D-R Panovski, Skopje (MK)
D-R Panovski, Skopje (MK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 5 ml
D-R Panovski, Skopje (MK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
D-R Panovski, Skopje (MK)
D-R Panovski, Skopje (MK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 1 mg
D-R Panovski, Skopje (MK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 2 mg
D-R Panovski, Skopje (MK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 5 mg
D-R Panovski, Skopje (MK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Amoxicillin Sodium / Potassium Clavulanate 1 g/220 mg/10 ml
D-R Panovski, Skopje (MK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Azithromycin 500 mg/5 ml
D-R Panovski, Skopje (MK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 1 g/10 ml
D-R Panovski, Skopje (MK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl Citrate 50 mcg/ml, 2 ml
D-R Panovski, Skopje (MK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 1 g/10 ml
D-R Panovski, Skopje (MK)
D-R Panovski, Skopje (MK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 2 g/10 ml
D-R Panovski, Skopje (MK)
D-R Panovski, Skopje (MK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Levofloxacin, 5 mg/ml/100 ml
D-R Panovski, Skopje (MK)
D-R Panovski, Skopje (MK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium, 10 mg/ml, 2,5 ml
D-R Panovski, Skopje (MK)
D-R Panovski, Skopje (MK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Piperacillin and Tazobactam, 2 g and 0,25 g/50 ml
D-R Panovski, Skopje (MK)
D-R Panovski, Skopje (MK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl Citrate 50 mcg/ml, 10 ml
D-R Panovski, Skopje (MK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Piperacillin and Tazobactam, 4 g and 0,5 g/100 ml
D-R Panovski, Skopje (MK)
D-R Panovski, Skopje (MK)
D-R Panovski, Skopje (MK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium, 10 mg/ml, 5 ml
D-R Panovski, Skopje (MK)
D-R Panovski, Skopje (MK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 5 ml
D-R Panovski, Skopje (MK)
D-R Panovski, Skopje (MK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 10 ml
D-R Panovski, Skopje (MK)
D-R Panovski, Skopje (MK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
D-R Panovski, Skopje (MK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 10 mg/ml, 1 ml
D-R Panovski, Skopje (MK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
D-R Panovski, Skopje (MK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
D-R Panovski, Skopje (MK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 4 ml
D-R Panovski, Skopje (MK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 10 ml
D-R Panovski, Skopje (MK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 1 mg/ml, 5 ml
D-R Panovski, Skopje (MK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 2 mg/ml, 50 ml
D-R Panovski, Skopje (MK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 1 ml
D-R Panovski, Skopje (MK)
D-R Panovski, Skopje (MK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 3 ml
D-R Panovski, Skopje (MK)
D-R Panovski, Skopje (MK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 10 mg/ml, 1 ml
D-R Panovski, Skopje (MK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 10 ml
D-R Panovski, Skopje (MK)
D-R Panovski, Skopje (MK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 10 ml
D-R Panovski, Skopje (MK)
D-R Panovski, Skopje (MK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 50 ml
D-R Panovski, Skopje (MK)
D-R Panovski, Skopje (MK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 100 ml
D-R Panovski, Skopje (MK)
D-R Panovski, Skopje (MK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 20 mg/ml, 50 ml
D-R Panovski, Skopje (MK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 20 mg/ml, 1 ml
D-R Panovski, Skopje (MK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dopamine, 40 mg/ml, 5 ml
D-R Panovski, Skopje (MK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Epinephrine/Adrenaline, 1 mg/ml, 1 ml
D-R Panovski, Skopje (MK)
D-R Panovski, Skopje (MK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 1 mg/ml,1 ml
D-R Panovski, Skopje (MK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 1 mg/ml, 4 ml
D-R Panovski, Skopje (MK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 2 mg/ml, 1 ml
D-R Panovski, Skopje (MK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin, 5K/1 ml, 5 ml
D-R Panovski, Skopje (MK)
D-R Panovski, Skopje (MK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 50 mcg/ml 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 500 mcg/ml 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 20 mg/ml, 1 ml
D-R Panovski, Skopje (MK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 50 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 60 mg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Amoxicillin sodium/Potassium clavulanate 1 g/100 mg/10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Levofloxacin 5 mg/ml/50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium 10 mg/ml, 25 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Mivacurium 2 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium 10 mg/1 ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine 100 mcg/ml 25 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Lorazepam 4 mg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam 5 mg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 30 mg/ml, 1ml
D-R Panovski, Skopje (MK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol 10 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease - Dobutamine 50 mg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dobutamine 5 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dopamine 200 mg/1 ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Epinephrine/Adrenaline 1 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 80 mcg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 1 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin 25 IU/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin 100 IU/ ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 50 mcg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 100 mg/ml, 5 ml
D-R Panovski, Skopje (MK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 2 mg/ml, 4 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 50 mcg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 5 mcg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 50 mcg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 2 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 10 ml
D-R Panovski, Skopje (MK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
D-R Panovski, Skopje (MK)
D-R Panovski, Skopje (MK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg /ml 2 ml
D-R Panovski, Skopje (MK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
D-R Panovski, Skopje (MK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexamethasone 4 mg/ml, 1 ml
Ever Valinject GmbH, Unterach (AT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Ever Valinject GmbH, Unterach (AT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Ever Valinject GmbH, Unterach (AT)
Ever Valinject GmbH, Unterach (AT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 4 ml
Ever Valinject GmbH, Unterach (AT)
Ever Valinject GmbH, Unterach (AT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 10 ml
Ever Valinject GmbH, Unterach (AT)
Ever Valinject GmbH, Unterach (AT)
Ever Valinject GmbH, Unterach (AT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 1 mg/ml, 5 ml
Ever Valinject GmbH, Unterach (AT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 3 ml
Ever Valinject GmbH, Unterach (AT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 50 ml
Ever Valinject GmbH, Unterach (AT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Ever Valinject GmbH, Unterach (AT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin, 5K/1 ml, 5 ml
Ever Valinject GmbH, Unterach (AT)
Ever Valinject GmbH, Unterach (AT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 5 ml
Ever Valinject GmbH, Unterach (AT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Ever Valinject GmbH, Unterach (AT)
Ever Valinject GmbH, Unterach (AT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 1 mg
Ever Valinject GmbH, Unterach (AT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 2 mg
Ever Valinject GmbH, Unterach (AT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 5 mg
Ever Valinject GmbH, Unterach (AT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Amoxicillin Sodium / Potassium Clavulanate 1 g/220 mg/10 ml
Ever Valinject GmbH, Unterach (AT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Azithromycin 500 mg/5 ml
Ever Valinject GmbH, Unterach (AT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 1 g/10 ml
Ever Valinject GmbH, Unterach (AT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl Citrate 50 mcg/ml, 2 ml
Ever Valinject GmbH, Unterach (AT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 1 g/10 ml
Ever Valinject GmbH, Unterach (AT)
Ever Valinject GmbH, Unterach (AT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 2 g/10 ml
Ever Valinject GmbH, Unterach (AT)
Ever Valinject GmbH, Unterach (AT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Levofloxacin, 5 mg/ml/100 ml
Ever Valinject GmbH, Unterach (AT)
Ever Valinject GmbH, Unterach (AT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium, 10 mg/ml, 2,5 ml
Ever Valinject GmbH, Unterach (AT)
Ever Valinject GmbH, Unterach (AT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Piperacillin and Tazobactam, 2 g and 0,25 g/50 ml
Ever Valinject GmbH, Unterach (AT)
Ever Valinject GmbH, Unterach (AT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl Citrate 50 mcg/ml, 10 ml
Ever Valinject GmbH, Unterach (AT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Piperacillin and Tazobactam, 4 g and 0,5 g/100 ml
Ever Valinject GmbH, Unterach (AT)
Ever Valinject GmbH, Unterach (AT)
Ever Valinject GmbH, Unterach (AT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium, 10 mg/ml, 5 ml
Ever Valinject GmbH, Unterach (AT)
Ever Valinject GmbH, Unterach (AT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 5 ml
Ever Valinject GmbH, Unterach (AT)
Ever Valinject GmbH, Unterach (AT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 10 ml
Ever Valinject GmbH, Unterach (AT)
Ever Valinject GmbH, Unterach (AT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Ever Valinject GmbH, Unterach (AT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 10 mg/ml, 1 ml
Ever Valinject GmbH, Unterach (AT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Ever Valinject GmbH, Unterach (AT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Ever Valinject GmbH, Unterach (AT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 4 ml
Ever Valinject GmbH, Unterach (AT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 10 ml
Ever Valinject GmbH, Unterach (AT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 1 mg/ml, 5 ml
Ever Valinject GmbH, Unterach (AT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 2 mg/ml, 50 ml
Ever Valinject GmbH, Unterach (AT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 1 ml
Ever Valinject GmbH, Unterach (AT)
Ever Valinject GmbH, Unterach (AT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 3 ml
Ever Valinject GmbH, Unterach (AT)
Ever Valinject GmbH, Unterach (AT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 10 mg/ml, 1 ml
Ever Valinject GmbH, Unterach (AT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 10 ml
Ever Valinject GmbH, Unterach (AT)
Ever Valinject GmbH, Unterach (AT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 10 ml
Ever Valinject GmbH, Unterach (AT)
Ever Valinject GmbH, Unterach (AT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 50 ml
Ever Valinject GmbH, Unterach (AT)
Ever Valinject GmbH, Unterach (AT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 100 ml
Ever Valinject GmbH, Unterach (AT)
Ever Valinject GmbH, Unterach (AT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 20 mg/ml, 50 ml
Ever Valinject GmbH, Unterach (AT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 20 mg/ml, 1 ml
Ever Valinject GmbH, Unterach (AT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dopamine, 40 mg/ml, 5 ml
Ever Valinject GmbH, Unterach (AT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Epinephrine/Adrenaline, 1 mg/ml, 1 ml
Ever Valinject GmbH, Unterach (AT)
Ever Valinject GmbH, Unterach (AT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 1 mg/ml,1 ml
Ever Valinject GmbH, Unterach (AT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 1 mg/ml, 4 ml
Ever Valinject GmbH, Unterach (AT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 2 mg/ml, 1 ml
Ever Valinject GmbH, Unterach (AT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin, 5K/1 ml, 5 ml
Ever Valinject GmbH, Unterach (AT)
Ever Valinject GmbH, Unterach (AT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 50 mcg/ml 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 500 mcg/ml 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 20 mg/ml, 1 ml
Ever Valinject GmbH, Unterach (AT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 50 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 60 mg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Amoxicillin sodium/Potassium clavulanate 1 g/100 mg/10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Levofloxacin 5 mg/ml/50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium 10 mg/ml, 25 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Mivacurium 2 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium 10 mg/1 ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine 100 mcg/ml 25 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Lorazepam 4 mg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam 5 mg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 30 mg/ml, 1ml
Ever Valinject GmbH, Unterach (AT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol 10 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease - Dobutamine 50 mg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dobutamine 5 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dopamine 200 mg/1 ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Epinephrine/Adrenaline 1 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 80 mcg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 1 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin 25 IU/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin 100 IU/ ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 50 mcg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 100 mg/ml, 5 ml
Ever Valinject GmbH, Unterach (AT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 2 mg/ml, 4 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 50 mcg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 5 mcg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 50 mcg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 2 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 10 ml
Ever Valinject GmbH, Unterach (AT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Ever Valinject GmbH, Unterach (AT)
Ever Valinject GmbH, Unterach (AT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg /ml 2 ml
Ever Valinject GmbH, Unterach (AT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Ever Valinject GmbH, Unterach (AT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexamethasone 4 mg/ml, 1 ml
Hikma Farmacêutica, Sintra (PT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Hikma Farmacêutica, Sintra (PT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Hikma Farmacêutica, Sintra (PT)
Hikma Farmacêutica, Sintra (PT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 4 ml
Hikma Farmacêutica, Sintra (PT)
Hikma Farmacêutica, Sintra (PT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 10 ml
Hikma Farmacêutica, Sintra (PT)
Hikma Farmacêutica, Sintra (PT)
Hikma Farmacêutica, Sintra (PT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 1 mg/ml, 5 ml
Hikma Farmacêutica, Sintra (PT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 3 ml
Hikma Farmacêutica, Sintra (PT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 50 ml
Hikma Farmacêutica, Sintra (PT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Hikma Farmacêutica, Sintra (PT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin, 5K/1 ml, 5 ml
Hikma Farmacêutica, Sintra (PT)
Hikma Farmacêutica, Sintra (PT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 5 ml
Hikma Farmacêutica, Sintra (PT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Hikma Farmacêutica, Sintra (PT)
Hikma Farmacêutica, Sintra (PT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 1 mg
Hikma Farmacêutica, Sintra (PT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 2 mg
Hikma Farmacêutica, Sintra (PT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 5 mg
Hikma Farmacêutica, Sintra (PT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Amoxicillin Sodium / Potassium Clavulanate 1 g/220 mg/10 ml
Hikma Farmacêutica, Sintra (PT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Azithromycin 500 mg/5 ml
Hikma Farmacêutica, Sintra (PT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 1 g/10 ml
Hikma Farmacêutica, Sintra (PT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl Citrate 50 mcg/ml, 2 ml
Hikma Farmacêutica, Sintra (PT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 1 g/10 ml
Hikma Farmacêutica, Sintra (PT)
Hikma Farmacêutica, Sintra (PT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 2 g/10 ml
Hikma Farmacêutica, Sintra (PT)
Hikma Farmacêutica, Sintra (PT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Levofloxacin, 5 mg/ml/100 ml
Hikma Farmacêutica, Sintra (PT)
Hikma Farmacêutica, Sintra (PT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium, 10 mg/ml, 2,5 ml
Hikma Farmacêutica, Sintra (PT)
Hikma Farmacêutica, Sintra (PT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Piperacillin and Tazobactam, 2 g and 0,25 g/50 ml
Hikma Farmacêutica, Sintra (PT)
Hikma Farmacêutica, Sintra (PT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl Citrate 50 mcg/ml, 10 ml
Hikma Farmacêutica, Sintra (PT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Piperacillin and Tazobactam, 4 g and 0,5 g/100 ml
Hikma Farmacêutica, Sintra (PT)
Hikma Farmacêutica, Sintra (PT)
Hikma Farmacêutica, Sintra (PT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium, 10 mg/ml, 5 ml
Hikma Farmacêutica, Sintra (PT)
Hikma Farmacêutica, Sintra (PT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 5 ml
Hikma Farmacêutica, Sintra (PT)
Hikma Farmacêutica, Sintra (PT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 10 ml
Hikma Farmacêutica, Sintra (PT)
Hikma Farmacêutica, Sintra (PT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Hikma Farmacêutica, Sintra (PT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 10 mg/ml, 1 ml
Hikma Farmacêutica, Sintra (PT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Hikma Farmacêutica, Sintra (PT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Hikma Farmacêutica, Sintra (PT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 4 ml
Hikma Farmacêutica, Sintra (PT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 10 ml
Hikma Farmacêutica, Sintra (PT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 1 mg/ml, 5 ml
Hikma Farmacêutica, Sintra (PT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 2 mg/ml, 50 ml
Hikma Farmacêutica, Sintra (PT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 1 ml
Hikma Farmacêutica, Sintra (PT)
Hikma Farmacêutica, Sintra (PT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 3 ml
Hikma Farmacêutica, Sintra (PT)
Hikma Farmacêutica, Sintra (PT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 10 mg/ml, 1 ml
Hikma Farmacêutica, Sintra (PT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 10 ml
Hikma Farmacêutica, Sintra (PT)
Hikma Farmacêutica, Sintra (PT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 10 ml
Hikma Farmacêutica, Sintra (PT)
Hikma Farmacêutica, Sintra (PT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 50 ml
Hikma Farmacêutica, Sintra (PT)
Hikma Farmacêutica, Sintra (PT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 100 ml
Hikma Farmacêutica, Sintra (PT)
Hikma Farmacêutica, Sintra (PT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 20 mg/ml, 50 ml
Hikma Farmacêutica, Sintra (PT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 20 mg/ml, 1 ml
Hikma Farmacêutica, Sintra (PT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dopamine, 40 mg/ml, 5 ml
Hikma Farmacêutica, Sintra (PT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Epinephrine/Adrenaline, 1 mg/ml, 1 ml
Hikma Farmacêutica, Sintra (PT)
Hikma Farmacêutica, Sintra (PT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 1 mg/ml,1 ml
Hikma Farmacêutica, Sintra (PT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 1 mg/ml, 4 ml
Hikma Farmacêutica, Sintra (PT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 2 mg/ml, 1 ml
Hikma Farmacêutica, Sintra (PT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin, 5K/1 ml, 5 ml
Hikma Farmacêutica, Sintra (PT)
Hikma Farmacêutica, Sintra (PT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 50 mcg/ml 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 500 mcg/ml 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 20 mg/ml, 1 ml
Hikma Farmacêutica, Sintra (PT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 50 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 60 mg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Amoxicillin sodium/Potassium clavulanate 1 g/100 mg/10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Levofloxacin 5 mg/ml/50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium 10 mg/ml, 25 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Mivacurium 2 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium 10 mg/1 ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine 100 mcg/ml 25 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Lorazepam 4 mg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam 5 mg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 30 mg/ml, 1ml
Hikma Farmacêutica, Sintra (PT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol 10 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease - Dobutamine 50 mg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dobutamine 5 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dopamine 200 mg/1 ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Epinephrine/Adrenaline 1 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 80 mcg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 1 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin 25 IU/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin 100 IU/ ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 50 mcg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 100 mg/ml, 5 ml
Hikma Farmacêutica, Sintra (PT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 2 mg/ml, 4 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 50 mcg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 5 mcg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 50 mcg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 2 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 10 ml
Hikma Farmacêutica, Sintra (PT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Hikma Farmacêutica, Sintra (PT)
Hikma Farmacêutica, Sintra (PT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg /ml 2 ml
Hikma Farmacêutica, Sintra (PT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Hikma Farmacêutica, Sintra (PT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexamethasone 4 mg/ml, 1 ml
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 4 ml
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 10 ml
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 1 mg/ml, 5 ml
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 3 ml
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 50 ml
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin, 5K/1 ml, 5 ml
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 5 ml
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 1 mg
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 2 mg
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 5 mg
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Amoxicillin Sodium / Potassium Clavulanate 1 g/220 mg/10 ml
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Azithromycin 500 mg/5 ml
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 1 g/10 ml
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl Citrate 50 mcg/ml, 2 ml
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 1 g/10 ml
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 2 g/10 ml
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Levofloxacin, 5 mg/ml/100 ml
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium, 10 mg/ml, 2,5 ml
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Piperacillin and Tazobactam, 2 g and 0,25 g/50 ml
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl Citrate 50 mcg/ml, 10 ml
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Piperacillin and Tazobactam, 4 g and 0,5 g/100 ml
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium, 10 mg/ml, 5 ml
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 5 ml
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 10 ml
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 10 mg/ml, 1 ml
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 4 ml
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 10 ml
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 1 mg/ml, 5 ml
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 2 mg/ml, 50 ml
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 1 ml
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 3 ml
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 10 mg/ml, 1 ml
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 10 ml
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 10 ml
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 50 ml
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 100 ml
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 20 mg/ml, 50 ml
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 20 mg/ml, 1 ml
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dopamine, 40 mg/ml, 5 ml
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Epinephrine/Adrenaline, 1 mg/ml, 1 ml
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 1 mg/ml,1 ml
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 1 mg/ml, 4 ml
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 2 mg/ml, 1 ml
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin, 5K/1 ml, 5 ml
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 50 mcg/ml 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 500 mcg/ml 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 20 mg/ml, 1 ml
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 50 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 60 mg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Amoxicillin sodium/Potassium clavulanate 1 g/100 mg/10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Levofloxacin 5 mg/ml/50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium 10 mg/ml, 25 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Mivacurium 2 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium 10 mg/1 ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine 100 mcg/ml 25 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Lorazepam 4 mg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam 5 mg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 30 mg/ml, 1ml
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol 10 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease - Dobutamine 50 mg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dobutamine 5 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dopamine 200 mg/1 ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Epinephrine/Adrenaline 1 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 80 mcg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 1 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin 25 IU/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin 100 IU/ ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 50 mcg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 100 mg/ml, 5 ml
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 2 mg/ml, 4 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 50 mcg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 5 mcg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 50 mcg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 2 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 10 ml
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg /ml 2 ml
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Laboratorio Farmacologico S.A.L.F. Spa, Cenate Sotto (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexamethasone 4 mg/ml, 1 ml
Monico S.p.A, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Monico S.p.A, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Monico S.p.A, Venezia (IT)
Monico S.p.A, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 4 ml
Monico S.p.A, Venezia (IT)
Monico S.p.A, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 10 ml
Monico S.p.A, Venezia (IT)
Monico S.p.A, Venezia (IT)
Monico S.p.A, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 1 mg/ml, 5 ml
Monico S.p.A, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 3 ml
Monico S.p.A, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 50 ml
Monico S.p.A, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Monico S.p.A, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin, 5K/1 ml, 5 ml
Monico S.p.A, Venezia (IT)
Monico S.p.A, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 5 ml
Monico S.p.A, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Monico S.p.A, Venezia (IT)
Monico S.p.A, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 1 mg
Monico S.p.A, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 2 mg
Monico S.p.A, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 5 mg
Monico S.p.A, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Amoxicillin Sodium / Potassium Clavulanate 1 g/220 mg/10 ml
Monico S.p.A, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Azithromycin 500 mg/5 ml
Monico S.p.A, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 1 g/10 ml
Monico S.p.A, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl Citrate 50 mcg/ml, 2 ml
Monico S.p.A, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 1 g/10 ml
Monico S.p.A, Venezia (IT)
Monico S.p.A, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 2 g/10 ml
Monico S.p.A, Venezia (IT)
Monico S.p.A, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Levofloxacin, 5 mg/ml/100 ml
Monico S.p.A, Venezia (IT)
Monico S.p.A, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium, 10 mg/ml, 2,5 ml
Monico S.p.A, Venezia (IT)
Monico S.p.A, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Piperacillin and Tazobactam, 2 g and 0,25 g/50 ml
Monico S.p.A, Venezia (IT)
Monico S.p.A, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl Citrate 50 mcg/ml, 10 ml
Monico S.p.A, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Piperacillin and Tazobactam, 4 g and 0,5 g/100 ml
Monico S.p.A, Venezia (IT)
Monico S.p.A, Venezia (IT)
Monico S.p.A, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium, 10 mg/ml, 5 ml
Monico S.p.A, Venezia (IT)
Monico S.p.A, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 5 ml
Monico S.p.A, Venezia (IT)
Monico S.p.A, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 10 ml
Monico S.p.A, Venezia (IT)
Monico S.p.A, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Monico S.p.A, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 10 mg/ml, 1 ml
Monico S.p.A, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Monico S.p.A, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Monico S.p.A, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 4 ml
Monico S.p.A, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 10 ml
Monico S.p.A, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 1 mg/ml, 5 ml
Monico S.p.A, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 2 mg/ml, 50 ml
Monico S.p.A, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 1 ml
Monico S.p.A, Venezia (IT)
Monico S.p.A, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 3 ml
Monico S.p.A, Venezia (IT)
Monico S.p.A, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 10 mg/ml, 1 ml
Monico S.p.A, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 10 ml
Monico S.p.A, Venezia (IT)
Monico S.p.A, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 10 ml
Monico S.p.A, Venezia (IT)
Monico S.p.A, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 50 ml
Monico S.p.A, Venezia (IT)
Monico S.p.A, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 100 ml
Monico S.p.A, Venezia (IT)
Monico S.p.A, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 20 mg/ml, 50 ml
Monico S.p.A, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 20 mg/ml, 1 ml
Monico S.p.A, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dopamine, 40 mg/ml, 5 ml
Monico S.p.A, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Epinephrine/Adrenaline, 1 mg/ml, 1 ml
Monico S.p.A, Venezia (IT)
Monico S.p.A, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 1 mg/ml,1 ml
Monico S.p.A, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 1 mg/ml, 4 ml
Monico S.p.A, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 2 mg/ml, 1 ml
Monico S.p.A, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin, 5K/1 ml, 5 ml
Monico S.p.A, Venezia (IT)
Monico S.p.A, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 50 mcg/ml 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 500 mcg/ml 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 20 mg/ml, 1 ml
Monico S.p.A, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 50 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 60 mg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Amoxicillin sodium/Potassium clavulanate 1 g/100 mg/10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Levofloxacin 5 mg/ml/50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium 10 mg/ml, 25 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Mivacurium 2 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium 10 mg/1 ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine 100 mcg/ml 25 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Lorazepam 4 mg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam 5 mg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 30 mg/ml, 1ml
Monico S.p.A, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol 10 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease - Dobutamine 50 mg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dobutamine 5 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dopamine 200 mg/1 ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Epinephrine/Adrenaline 1 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 80 mcg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 1 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin 25 IU/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin 100 IU/ ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 50 mcg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 100 mg/ml, 5 ml
Monico S.p.A, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 2 mg/ml, 4 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 50 mcg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 5 mcg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 50 mcg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 2 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 10 ml
Monico S.p.A, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Monico S.p.A, Venezia (IT)
Monico S.p.A, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg /ml 2 ml
Monico S.p.A, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Monico S.p.A, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexamethasone 4 mg/ml, 1 ml
Monico SPA, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Monico SPA, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Monico SPA, Venezia (IT)
Monico SPA, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 4 ml
Monico SPA, Venezia (IT)
Monico SPA, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 10 ml
Monico SPA, Venezia (IT)
Monico SPA, Venezia (IT)
Monico SPA, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 1 mg/ml, 5 ml
Monico SPA, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 3 ml
Monico SPA, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 50 ml
Monico SPA, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Monico SPA, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin, 5K/1 ml, 5 ml
Monico SPA, Venezia (IT)
Monico SPA, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 5 ml
Monico SPA, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Monico SPA, Venezia (IT)
Monico SPA, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 1 mg
Monico SPA, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 2 mg
Monico SPA, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 5 mg
Monico SPA, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Amoxicillin Sodium / Potassium Clavulanate 1 g/220 mg/10 ml
Monico SPA, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Azithromycin 500 mg/5 ml
Monico SPA, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 1 g/10 ml
Monico SPA, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl Citrate 50 mcg/ml, 2 ml
Monico SPA, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 1 g/10 ml
Monico SPA, Venezia (IT)
Monico SPA, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 2 g/10 ml
Monico SPA, Venezia (IT)
Monico SPA, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Levofloxacin, 5 mg/ml/100 ml
Monico SPA, Venezia (IT)
Monico SPA, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium, 10 mg/ml, 2,5 ml
Monico SPA, Venezia (IT)
Monico SPA, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Piperacillin and Tazobactam, 2 g and 0,25 g/50 ml
Monico SPA, Venezia (IT)
Monico SPA, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl Citrate 50 mcg/ml, 10 ml
Monico SPA, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Piperacillin and Tazobactam, 4 g and 0,5 g/100 ml
Monico SPA, Venezia (IT)
Monico SPA, Venezia (IT)
Monico SPA, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium, 10 mg/ml, 5 ml
Monico SPA, Venezia (IT)
Monico SPA, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 5 ml
Monico SPA, Venezia (IT)
Monico SPA, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 10 ml
Monico SPA, Venezia (IT)
Monico SPA, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Monico SPA, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 10 mg/ml, 1 ml
Monico SPA, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Monico SPA, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Monico SPA, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 4 ml
Monico SPA, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 10 ml
Monico SPA, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 1 mg/ml, 5 ml
Monico SPA, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 2 mg/ml, 50 ml
Monico SPA, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 1 ml
Monico SPA, Venezia (IT)
Monico SPA, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 3 ml
Monico SPA, Venezia (IT)
Monico SPA, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 10 mg/ml, 1 ml
Monico SPA, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 10 ml
Monico SPA, Venezia (IT)
Monico SPA, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 10 ml
Monico SPA, Venezia (IT)
Monico SPA, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 50 ml
Monico SPA, Venezia (IT)
Monico SPA, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 100 ml
Monico SPA, Venezia (IT)
Monico SPA, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 20 mg/ml, 50 ml
Monico SPA, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 20 mg/ml, 1 ml
Monico SPA, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dopamine, 40 mg/ml, 5 ml
Monico SPA, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Epinephrine/Adrenaline, 1 mg/ml, 1 ml
Monico SPA, Venezia (IT)
Monico SPA, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 1 mg/ml,1 ml
Monico SPA, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 1 mg/ml, 4 ml
Monico SPA, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 2 mg/ml, 1 ml
Monico SPA, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin, 5K/1 ml, 5 ml
Monico SPA, Venezia (IT)
Monico SPA, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 50 mcg/ml 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 500 mcg/ml 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 20 mg/ml, 1 ml
Monico SPA, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 50 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 60 mg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Amoxicillin sodium/Potassium clavulanate 1 g/100 mg/10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Levofloxacin 5 mg/ml/50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium 10 mg/ml, 25 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Mivacurium 2 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium 10 mg/1 ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine 100 mcg/ml 25 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Lorazepam 4 mg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam 5 mg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 30 mg/ml, 1ml
Monico SPA, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol 10 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease - Dobutamine 50 mg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dobutamine 5 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dopamine 200 mg/1 ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Epinephrine/Adrenaline 1 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 80 mcg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 1 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin 25 IU/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin 100 IU/ ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 50 mcg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 100 mg/ml, 5 ml
Monico SPA, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 2 mg/ml, 4 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 50 mcg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 5 mcg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 50 mcg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 2 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 10 ml
Monico SPA, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Monico SPA, Venezia (IT)
Monico SPA, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg /ml 2 ml
Monico SPA, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Monico SPA, Venezia (IT)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexamethasone 4 mg/ml, 1 ml
Mylan UK Healthcare Limited, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Mylan UK Healthcare Limited, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Mylan UK Healthcare Limited, Hatfield (UK)
Mylan UK Healthcare Limited, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 4 ml
Mylan UK Healthcare Limited, Hatfield (UK)
Mylan UK Healthcare Limited, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 10 ml
Mylan UK Healthcare Limited, Hatfield (UK)
Mylan UK Healthcare Limited, Hatfield (UK)
Mylan UK Healthcare Limited, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 1 mg/ml, 5 ml
Mylan UK Healthcare Limited, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 3 ml
Mylan UK Healthcare Limited, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 50 ml
Mylan UK Healthcare Limited, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Mylan UK Healthcare Limited, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin, 5K/1 ml, 5 ml
Mylan UK Healthcare Limited, Hatfield (UK)
Mylan UK Healthcare Limited, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 5 ml
Mylan UK Healthcare Limited, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Mylan UK Healthcare Limited, Hatfield (UK)
Mylan UK Healthcare Limited, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 1 mg
Mylan UK Healthcare Limited, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 2 mg
Mylan UK Healthcare Limited, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 5 mg
Mylan UK Healthcare Limited, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Amoxicillin Sodium / Potassium Clavulanate 1 g/220 mg/10 ml
Mylan UK Healthcare Limited, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Azithromycin 500 mg/5 ml
Mylan UK Healthcare Limited, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 1 g/10 ml
Mylan UK Healthcare Limited, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl Citrate 50 mcg/ml, 2 ml
Mylan UK Healthcare Limited, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 1 g/10 ml
Mylan UK Healthcare Limited, Hatfield (UK)
Mylan UK Healthcare Limited, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 2 g/10 ml
Mylan UK Healthcare Limited, Hatfield (UK)
Mylan UK Healthcare Limited, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Levofloxacin, 5 mg/ml/100 ml
Mylan UK Healthcare Limited, Hatfield (UK)
Mylan UK Healthcare Limited, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium, 10 mg/ml, 2,5 ml
Mylan UK Healthcare Limited, Hatfield (UK)
Mylan UK Healthcare Limited, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Piperacillin and Tazobactam, 2 g and 0,25 g/50 ml
Mylan UK Healthcare Limited, Hatfield (UK)
Mylan UK Healthcare Limited, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl Citrate 50 mcg/ml, 10 ml
Mylan UK Healthcare Limited, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Piperacillin and Tazobactam, 4 g and 0,5 g/100 ml
Mylan UK Healthcare Limited, Hatfield (UK)
Mylan UK Healthcare Limited, Hatfield (UK)
Mylan UK Healthcare Limited, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium, 10 mg/ml, 5 ml
Mylan UK Healthcare Limited, Hatfield (UK)
Mylan UK Healthcare Limited, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 5 ml
Mylan UK Healthcare Limited, Hatfield (UK)
Mylan UK Healthcare Limited, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 10 ml
Mylan UK Healthcare Limited, Hatfield (UK)
Mylan UK Healthcare Limited, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Mylan UK Healthcare Limited, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 10 mg/ml, 1 ml
Mylan UK Healthcare Limited, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Mylan UK Healthcare Limited, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Mylan UK Healthcare Limited, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 4 ml
Mylan UK Healthcare Limited, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 10 ml
Mylan UK Healthcare Limited, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 1 mg/ml, 5 ml
Mylan UK Healthcare Limited, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 2 mg/ml, 50 ml
Mylan UK Healthcare Limited, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 1 ml
Mylan UK Healthcare Limited, Hatfield (UK)
Mylan UK Healthcare Limited, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 3 ml
Mylan UK Healthcare Limited, Hatfield (UK)
Mylan UK Healthcare Limited, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 10 mg/ml, 1 ml
Mylan UK Healthcare Limited, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 10 ml
Mylan UK Healthcare Limited, Hatfield (UK)
Mylan UK Healthcare Limited, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 10 ml
Mylan UK Healthcare Limited, Hatfield (UK)
Mylan UK Healthcare Limited, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 50 ml
Mylan UK Healthcare Limited, Hatfield (UK)
Mylan UK Healthcare Limited, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 100 ml
Mylan UK Healthcare Limited, Hatfield (UK)
Mylan UK Healthcare Limited, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 20 mg/ml, 50 ml
Mylan UK Healthcare Limited, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 20 mg/ml, 1 ml
Mylan UK Healthcare Limited, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dopamine, 40 mg/ml, 5 ml
Mylan UK Healthcare Limited, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Epinephrine/Adrenaline, 1 mg/ml, 1 ml
Mylan UK Healthcare Limited, Hatfield (UK)
Mylan UK Healthcare Limited, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 1 mg/ml,1 ml
Mylan UK Healthcare Limited, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 1 mg/ml, 4 ml
Mylan UK Healthcare Limited, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 2 mg/ml, 1 ml
Mylan UK Healthcare Limited, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin, 5K/1 ml, 5 ml
Mylan UK Healthcare Limited, Hatfield (UK)
Mylan UK Healthcare Limited, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 50 mcg/ml 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 500 mcg/ml 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 20 mg/ml, 1 ml
Mylan UK Healthcare Limited, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 50 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 60 mg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Amoxicillin sodium/Potassium clavulanate 1 g/100 mg/10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Levofloxacin 5 mg/ml/50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium 10 mg/ml, 25 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Mivacurium 2 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium 10 mg/1 ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine 100 mcg/ml 25 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Lorazepam 4 mg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam 5 mg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 30 mg/ml, 1ml
Mylan UK Healthcare Limited, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol 10 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease - Dobutamine 50 mg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dobutamine 5 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dopamine 200 mg/1 ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Epinephrine/Adrenaline 1 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 80 mcg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 1 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin 25 IU/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin 100 IU/ ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 50 mcg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 100 mg/ml, 5 ml
Mylan UK Healthcare Limited, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 2 mg/ml, 4 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 50 mcg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 5 mcg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 50 mcg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 2 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 10 ml
Mylan UK Healthcare Limited, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Mylan UK Healthcare Limited, Hatfield (UK)
Mylan UK Healthcare Limited, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg /ml 2 ml
Mylan UK Healthcare Limited, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Mylan UK Healthcare Limited, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexamethasone 4 mg/ml, 1 ml
Mylan UK Healthcare Ltd, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Mylan UK Healthcare Ltd, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Mylan UK Healthcare Ltd, Hatfield (UK)
Mylan UK Healthcare Ltd, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 4 ml
Mylan UK Healthcare Ltd, Hatfield (UK)
Mylan UK Healthcare Ltd, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 10 ml
Mylan UK Healthcare Ltd, Hatfield (UK)
Mylan UK Healthcare Ltd, Hatfield (UK)
Mylan UK Healthcare Ltd, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 1 mg/ml, 5 ml
Mylan UK Healthcare Ltd, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 3 ml
Mylan UK Healthcare Ltd, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 50 ml
Mylan UK Healthcare Ltd, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Mylan UK Healthcare Ltd, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin, 5K/1 ml, 5 ml
Mylan UK Healthcare Ltd, Hatfield (UK)
Mylan UK Healthcare Ltd, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 5 ml
Mylan UK Healthcare Ltd, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Mylan UK Healthcare Ltd, Hatfield (UK)
Mylan UK Healthcare Ltd, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 1 mg
Mylan UK Healthcare Ltd, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 2 mg
Mylan UK Healthcare Ltd, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 5 mg
Mylan UK Healthcare Ltd, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Amoxicillin Sodium / Potassium Clavulanate 1 g/220 mg/10 ml
Mylan UK Healthcare Ltd, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Azithromycin 500 mg/5 ml
Mylan UK Healthcare Ltd, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 1 g/10 ml
Mylan UK Healthcare Ltd, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl Citrate 50 mcg/ml, 2 ml
Mylan UK Healthcare Ltd, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 1 g/10 ml
Mylan UK Healthcare Ltd, Hatfield (UK)
Mylan UK Healthcare Ltd, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 2 g/10 ml
Mylan UK Healthcare Ltd, Hatfield (UK)
Mylan UK Healthcare Ltd, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Levofloxacin, 5 mg/ml/100 ml
Mylan UK Healthcare Ltd, Hatfield (UK)
Mylan UK Healthcare Ltd, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium, 10 mg/ml, 2,5 ml
Mylan UK Healthcare Ltd, Hatfield (UK)
Mylan UK Healthcare Ltd, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Piperacillin and Tazobactam, 2 g and 0,25 g/50 ml
Mylan UK Healthcare Ltd, Hatfield (UK)
Mylan UK Healthcare Ltd, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl Citrate 50 mcg/ml, 10 ml
Mylan UK Healthcare Ltd, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Piperacillin and Tazobactam, 4 g and 0,5 g/100 ml
Mylan UK Healthcare Ltd, Hatfield (UK)
Mylan UK Healthcare Ltd, Hatfield (UK)
Mylan UK Healthcare Ltd, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium, 10 mg/ml, 5 ml
Mylan UK Healthcare Ltd, Hatfield (UK)
Mylan UK Healthcare Ltd, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 5 ml
Mylan UK Healthcare Ltd, Hatfield (UK)
Mylan UK Healthcare Ltd, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 10 ml
Mylan UK Healthcare Ltd, Hatfield (UK)
Mylan UK Healthcare Ltd, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Mylan UK Healthcare Ltd, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 10 mg/ml, 1 ml
Mylan UK Healthcare Ltd, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Mylan UK Healthcare Ltd, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Mylan UK Healthcare Ltd, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 4 ml
Mylan UK Healthcare Ltd, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 10 ml
Mylan UK Healthcare Ltd, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 1 mg/ml, 5 ml
Mylan UK Healthcare Ltd, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 2 mg/ml, 50 ml
Mylan UK Healthcare Ltd, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 1 ml
Mylan UK Healthcare Ltd, Hatfield (UK)
Mylan UK Healthcare Ltd, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 3 ml
Mylan UK Healthcare Ltd, Hatfield (UK)
Mylan UK Healthcare Ltd, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 10 mg/ml, 1 ml
Mylan UK Healthcare Ltd, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 10 ml
Mylan UK Healthcare Ltd, Hatfield (UK)
Mylan UK Healthcare Ltd, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 10 ml
Mylan UK Healthcare Ltd, Hatfield (UK)
Mylan UK Healthcare Ltd, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 50 ml
Mylan UK Healthcare Ltd, Hatfield (UK)
Mylan UK Healthcare Ltd, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 100 ml
Mylan UK Healthcare Ltd, Hatfield (UK)
Mylan UK Healthcare Ltd, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 20 mg/ml, 50 ml
Mylan UK Healthcare Ltd, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 20 mg/ml, 1 ml
Mylan UK Healthcare Ltd, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dopamine, 40 mg/ml, 5 ml
Mylan UK Healthcare Ltd, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Epinephrine/Adrenaline, 1 mg/ml, 1 ml
Mylan UK Healthcare Ltd, Hatfield (UK)
Mylan UK Healthcare Ltd, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 1 mg/ml,1 ml
Mylan UK Healthcare Ltd, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 1 mg/ml, 4 ml
Mylan UK Healthcare Ltd, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 2 mg/ml, 1 ml
Mylan UK Healthcare Ltd, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin, 5K/1 ml, 5 ml
Mylan UK Healthcare Ltd, Hatfield (UK)
Mylan UK Healthcare Ltd, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 50 mcg/ml 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 500 mcg/ml 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 20 mg/ml, 1 ml
Mylan UK Healthcare Ltd, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 50 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 60 mg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Amoxicillin sodium/Potassium clavulanate 1 g/100 mg/10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Levofloxacin 5 mg/ml/50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium 10 mg/ml, 25 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Mivacurium 2 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium 10 mg/1 ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine 100 mcg/ml 25 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Lorazepam 4 mg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam 5 mg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 30 mg/ml, 1ml
Mylan UK Healthcare Ltd, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol 10 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease - Dobutamine 50 mg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dobutamine 5 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dopamine 200 mg/1 ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Epinephrine/Adrenaline 1 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 80 mcg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 1 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin 25 IU/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin 100 IU/ ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 50 mcg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 100 mg/ml, 5 ml
Mylan UK Healthcare Ltd, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 2 mg/ml, 4 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 50 mcg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 5 mcg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 50 mcg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 2 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 10 ml
Mylan UK Healthcare Ltd, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Mylan UK Healthcare Ltd, Hatfield (UK)
Mylan UK Healthcare Ltd, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg /ml 2 ml
Mylan UK Healthcare Ltd, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Mylan UK Healthcare Ltd, Hatfield (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexamethasone 4 mg/ml, 1 ml
Orion Oyj, Espoo (FI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Orion Oyj, Espoo (FI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Orion Oyj, Espoo (FI)
Orion Oyj, Espoo (FI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 4 ml
Orion Oyj, Espoo (FI)
Orion Oyj, Espoo (FI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 10 ml
Orion Oyj, Espoo (FI)
Orion Oyj, Espoo (FI)
Orion Oyj, Espoo (FI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 1 mg/ml, 5 ml
Orion Oyj, Espoo (FI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 3 ml
Orion Oyj, Espoo (FI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 50 ml
Orion Oyj, Espoo (FI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Orion Oyj, Espoo (FI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin, 5K/1 ml, 5 ml
Orion Oyj, Espoo (FI)
Orion Oyj, Espoo (FI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 5 ml
Orion Oyj, Espoo (FI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Orion Oyj, Espoo (FI)
Orion Oyj, Espoo (FI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 1 mg
Orion Oyj, Espoo (FI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 2 mg
Orion Oyj, Espoo (FI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 5 mg
Orion Oyj, Espoo (FI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Amoxicillin Sodium / Potassium Clavulanate 1 g/220 mg/10 ml
Orion Oyj, Espoo (FI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Azithromycin 500 mg/5 ml
Orion Oyj, Espoo (FI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 1 g/10 ml
Orion Oyj, Espoo (FI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl Citrate 50 mcg/ml, 2 ml
Orion Oyj, Espoo (FI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 1 g/10 ml
Orion Oyj, Espoo (FI)
Orion Oyj, Espoo (FI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 2 g/10 ml
Orion Oyj, Espoo (FI)
Orion Oyj, Espoo (FI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Levofloxacin, 5 mg/ml/100 ml
Orion Oyj, Espoo (FI)
Orion Oyj, Espoo (FI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium, 10 mg/ml, 2,5 ml
Orion Oyj, Espoo (FI)
Orion Oyj, Espoo (FI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Piperacillin and Tazobactam, 2 g and 0,25 g/50 ml
Orion Oyj, Espoo (FI)
Orion Oyj, Espoo (FI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl Citrate 50 mcg/ml, 10 ml
Orion Oyj, Espoo (FI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Piperacillin and Tazobactam, 4 g and 0,5 g/100 ml
Orion Oyj, Espoo (FI)
Orion Oyj, Espoo (FI)
Orion Oyj, Espoo (FI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium, 10 mg/ml, 5 ml
Orion Oyj, Espoo (FI)
Orion Oyj, Espoo (FI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 5 ml
Orion Oyj, Espoo (FI)
Orion Oyj, Espoo (FI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 10 ml
Orion Oyj, Espoo (FI)
Orion Oyj, Espoo (FI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Orion Oyj, Espoo (FI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 10 mg/ml, 1 ml
Orion Oyj, Espoo (FI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Orion Oyj, Espoo (FI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Orion Oyj, Espoo (FI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 4 ml
Orion Oyj, Espoo (FI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 10 ml
Orion Oyj, Espoo (FI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 1 mg/ml, 5 ml
Orion Oyj, Espoo (FI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 2 mg/ml, 50 ml
Orion Oyj, Espoo (FI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 1 ml
Orion Oyj, Espoo (FI)
Orion Oyj, Espoo (FI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 3 ml
Orion Oyj, Espoo (FI)
Orion Oyj, Espoo (FI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 10 mg/ml, 1 ml
Orion Oyj, Espoo (FI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 10 ml
Orion Oyj, Espoo (FI)
Orion Oyj, Espoo (FI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 10 ml
Orion Oyj, Espoo (FI)
Orion Oyj, Espoo (FI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 50 ml
Orion Oyj, Espoo (FI)
Orion Oyj, Espoo (FI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 100 ml
Orion Oyj, Espoo (FI)
Orion Oyj, Espoo (FI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 20 mg/ml, 50 ml
Orion Oyj, Espoo (FI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 20 mg/ml, 1 ml
Orion Oyj, Espoo (FI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dopamine, 40 mg/ml, 5 ml
Orion Oyj, Espoo (FI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Epinephrine/Adrenaline, 1 mg/ml, 1 ml
Orion Oyj, Espoo (FI)
Orion Oyj, Espoo (FI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 1 mg/ml,1 ml
Orion Oyj, Espoo (FI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 1 mg/ml, 4 ml
Orion Oyj, Espoo (FI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 2 mg/ml, 1 ml
Orion Oyj, Espoo (FI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin, 5K/1 ml, 5 ml
Orion Oyj, Espoo (FI)
Orion Oyj, Espoo (FI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 50 mcg/ml 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 500 mcg/ml 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 20 mg/ml, 1 ml
Orion Oyj, Espoo (FI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 50 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 60 mg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Amoxicillin sodium/Potassium clavulanate 1 g/100 mg/10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Levofloxacin 5 mg/ml/50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium 10 mg/ml, 25 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Mivacurium 2 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium 10 mg/1 ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine 100 mcg/ml 25 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Lorazepam 4 mg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam 5 mg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 30 mg/ml, 1ml
Orion Oyj, Espoo (FI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol 10 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease - Dobutamine 50 mg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dobutamine 5 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dopamine 200 mg/1 ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Epinephrine/Adrenaline 1 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 80 mcg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 1 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin 25 IU/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin 100 IU/ ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 50 mcg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 100 mg/ml, 5 ml
Orion Oyj, Espoo (FI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 2 mg/ml, 4 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 50 mcg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 5 mcg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 50 mcg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 2 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 10 ml
Orion Oyj, Espoo (FI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Orion Oyj, Espoo (FI)
Orion Oyj, Espoo (FI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg /ml 2 ml
Orion Oyj, Espoo (FI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Orion Oyj, Espoo (FI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexamethasone 4 mg/ml, 1 ml
Panpaharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Panpaharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Panpaharma SA, Luitré (FR)
Panpaharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 4 ml
Panpaharma SA, Luitré (FR)
Panpaharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 10 ml
Panpaharma SA, Luitré (FR)
Panpaharma SA, Luitré (FR)
Panpaharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 1 mg/ml, 5 ml
Panpaharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 3 ml
Panpaharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 50 ml
Panpaharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Panpaharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin, 5K/1 ml, 5 ml
Panpaharma SA, Luitré (FR)
Panpaharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 5 ml
Panpaharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Panpaharma SA, Luitré (FR)
Panpaharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 1 mg
Panpaharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 2 mg
Panpaharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 5 mg
Panpaharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Amoxicillin Sodium / Potassium Clavulanate 1 g/220 mg/10 ml
Panpaharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Azithromycin 500 mg/5 ml
Panpaharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 1 g/10 ml
Panpaharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl Citrate 50 mcg/ml, 2 ml
Panpaharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 1 g/10 ml
Panpaharma SA, Luitré (FR)
Panpaharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 2 g/10 ml
Panpaharma SA, Luitré (FR)
Panpaharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Levofloxacin, 5 mg/ml/100 ml
Panpaharma SA, Luitré (FR)
Panpaharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium, 10 mg/ml, 2,5 ml
Panpaharma SA, Luitré (FR)
Panpaharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Piperacillin and Tazobactam, 2 g and 0,25 g/50 ml
Panpaharma SA, Luitré (FR)
Panpaharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl Citrate 50 mcg/ml, 10 ml
Panpaharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Piperacillin and Tazobactam, 4 g and 0,5 g/100 ml
Panpaharma SA, Luitré (FR)
Panpaharma SA, Luitré (FR)
Panpaharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium, 10 mg/ml, 5 ml
Panpaharma SA, Luitré (FR)
Panpaharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 5 ml
Panpaharma SA, Luitré (FR)
Panpaharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 10 ml
Panpaharma SA, Luitré (FR)
Panpaharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Panpaharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 10 mg/ml, 1 ml
Panpaharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Panpaharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Panpaharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 4 ml
Panpaharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 10 ml
Panpaharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 1 mg/ml, 5 ml
Panpaharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 2 mg/ml, 50 ml
Panpaharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 1 ml
Panpaharma SA, Luitré (FR)
Panpaharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 3 ml
Panpaharma SA, Luitré (FR)
Panpaharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 10 mg/ml, 1 ml
Panpaharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 10 ml
Panpaharma SA, Luitré (FR)
Panpaharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 10 ml
Panpaharma SA, Luitré (FR)
Panpaharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 50 ml
Panpaharma SA, Luitré (FR)
Panpaharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 100 ml
Panpaharma SA, Luitré (FR)
Panpaharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 20 mg/ml, 50 ml
Panpaharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 20 mg/ml, 1 ml
Panpaharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dopamine, 40 mg/ml, 5 ml
Panpaharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Epinephrine/Adrenaline, 1 mg/ml, 1 ml
Panpaharma SA, Luitré (FR)
Panpaharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 1 mg/ml,1 ml
Panpaharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 1 mg/ml, 4 ml
Panpaharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 2 mg/ml, 1 ml
Panpaharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin, 5K/1 ml, 5 ml
Panpaharma SA, Luitré (FR)
Panpaharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 50 mcg/ml 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 500 mcg/ml 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 20 mg/ml, 1 ml
Panpaharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 50 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 60 mg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Amoxicillin sodium/Potassium clavulanate 1 g/100 mg/10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Levofloxacin 5 mg/ml/50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium 10 mg/ml, 25 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Mivacurium 2 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium 10 mg/1 ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine 100 mcg/ml 25 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Lorazepam 4 mg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam 5 mg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 30 mg/ml, 1ml
Panpaharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol 10 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease - Dobutamine 50 mg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dobutamine 5 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dopamine 200 mg/1 ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Epinephrine/Adrenaline 1 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 80 mcg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 1 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin 25 IU/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin 100 IU/ ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 50 mcg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 100 mg/ml, 5 ml
Panpaharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 2 mg/ml, 4 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 50 mcg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 5 mcg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 50 mcg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 2 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 10 ml
Panpaharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Panpaharma SA, Luitré (FR)
Panpaharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg /ml 2 ml
Panpaharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Panpaharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexamethasone 4 mg/ml, 1 ml
Panpharma S.A, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Panpharma S.A, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Panpharma S.A, Luitré (FR)
Panpharma S.A, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 4 ml
Panpharma S.A, Luitré (FR)
Panpharma S.A, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 10 ml
Panpharma S.A, Luitré (FR)
Panpharma S.A, Luitré (FR)
Panpharma S.A, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 1 mg/ml, 5 ml
Panpharma S.A, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 3 ml
Panpharma S.A, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 50 ml
Panpharma S.A, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Panpharma S.A, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin, 5K/1 ml, 5 ml
Panpharma S.A, Luitré (FR)
Panpharma S.A, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 5 ml
Panpharma S.A, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Panpharma S.A, Luitré (FR)
Panpharma S.A, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 1 mg
Panpharma S.A, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 2 mg
Panpharma S.A, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 5 mg
Panpharma S.A, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Amoxicillin Sodium / Potassium Clavulanate 1 g/220 mg/10 ml
Panpharma S.A, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Azithromycin 500 mg/5 ml
Panpharma S.A, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 1 g/10 ml
Panpharma S.A, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl Citrate 50 mcg/ml, 2 ml
Panpharma S.A, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 1 g/10 ml
Panpharma S.A, Luitré (FR)
Panpharma S.A, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 2 g/10 ml
Panpharma S.A, Luitré (FR)
Panpharma S.A, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Levofloxacin, 5 mg/ml/100 ml
Panpharma S.A, Luitré (FR)
Panpharma S.A, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium, 10 mg/ml, 2,5 ml
Panpharma S.A, Luitré (FR)
Panpharma S.A, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Piperacillin and Tazobactam, 2 g and 0,25 g/50 ml
Panpharma S.A, Luitré (FR)
Panpharma S.A, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl Citrate 50 mcg/ml, 10 ml
Panpharma S.A, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Piperacillin and Tazobactam, 4 g and 0,5 g/100 ml
Panpharma S.A, Luitré (FR)
Panpharma S.A, Luitré (FR)
Panpharma S.A, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium, 10 mg/ml, 5 ml
Panpharma S.A, Luitré (FR)
Panpharma S.A, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 5 ml
Panpharma S.A, Luitré (FR)
Panpharma S.A, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 10 ml
Panpharma S.A, Luitré (FR)
Panpharma S.A, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Panpharma S.A, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 10 mg/ml, 1 ml
Panpharma S.A, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Panpharma S.A, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Panpharma S.A, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 4 ml
Panpharma S.A, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 10 ml
Panpharma S.A, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 1 mg/ml, 5 ml
Panpharma S.A, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 2 mg/ml, 50 ml
Panpharma S.A, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 1 ml
Panpharma S.A, Luitré (FR)
Panpharma S.A, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 3 ml
Panpharma S.A, Luitré (FR)
Panpharma S.A, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 10 mg/ml, 1 ml
Panpharma S.A, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 10 ml
Panpharma S.A, Luitré (FR)
Panpharma S.A, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 10 ml
Panpharma S.A, Luitré (FR)
Panpharma S.A, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 50 ml
Panpharma S.A, Luitré (FR)
Panpharma S.A, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 100 ml
Panpharma S.A, Luitré (FR)
Panpharma S.A, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 20 mg/ml, 50 ml
Panpharma S.A, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 20 mg/ml, 1 ml
Panpharma S.A, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dopamine, 40 mg/ml, 5 ml
Panpharma S.A, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Epinephrine/Adrenaline, 1 mg/ml, 1 ml
Panpharma S.A, Luitré (FR)
Panpharma S.A, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 1 mg/ml,1 ml
Panpharma S.A, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 1 mg/ml, 4 ml
Panpharma S.A, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 2 mg/ml, 1 ml
Panpharma S.A, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin, 5K/1 ml, 5 ml
Panpharma S.A, Luitré (FR)
Panpharma S.A, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 50 mcg/ml 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 500 mcg/ml 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 20 mg/ml, 1 ml
Panpharma S.A, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 50 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 60 mg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Amoxicillin sodium/Potassium clavulanate 1 g/100 mg/10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Levofloxacin 5 mg/ml/50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium 10 mg/ml, 25 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Mivacurium 2 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium 10 mg/1 ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine 100 mcg/ml 25 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Lorazepam 4 mg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam 5 mg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 30 mg/ml, 1ml
Panpharma S.A, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol 10 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease - Dobutamine 50 mg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dobutamine 5 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dopamine 200 mg/1 ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Epinephrine/Adrenaline 1 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 80 mcg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 1 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin 25 IU/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin 100 IU/ ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 50 mcg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 100 mg/ml, 5 ml
Panpharma S.A, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 2 mg/ml, 4 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 50 mcg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 5 mcg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 50 mcg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 2 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 10 ml
Panpharma S.A, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Panpharma S.A, Luitré (FR)
Panpharma S.A, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg /ml 2 ml
Panpharma S.A, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Panpharma S.A, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexamethasone 4 mg/ml, 1 ml
Panpharma S.A., Luitre (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Panpharma S.A., Luitre (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Panpharma S.A., Luitre (FR)
Panpharma S.A., Luitre (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 4 ml
Panpharma S.A., Luitre (FR)
Panpharma S.A., Luitre (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 10 ml
Panpharma S.A., Luitre (FR)
Panpharma S.A., Luitre (FR)
Panpharma S.A., Luitre (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 1 mg/ml, 5 ml
Panpharma S.A., Luitre (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 3 ml
Panpharma S.A., Luitre (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 50 ml
Panpharma S.A., Luitre (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Panpharma S.A., Luitre (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin, 5K/1 ml, 5 ml
Panpharma S.A., Luitre (FR)
Panpharma S.A., Luitre (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 5 ml
Panpharma S.A., Luitre (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Panpharma S.A., Luitre (FR)
Panpharma S.A., Luitre (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 1 mg
Panpharma S.A., Luitre (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 2 mg
Panpharma S.A., Luitre (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 5 mg
Panpharma S.A., Luitre (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Amoxicillin Sodium / Potassium Clavulanate 1 g/220 mg/10 ml
Panpharma S.A., Luitre (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Azithromycin 500 mg/5 ml
Panpharma S.A., Luitre (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 1 g/10 ml
Panpharma S.A., Luitre (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl Citrate 50 mcg/ml, 2 ml
Panpharma S.A., Luitre (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 1 g/10 ml
Panpharma S.A., Luitre (FR)
Panpharma S.A., Luitre (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 2 g/10 ml
Panpharma S.A., Luitre (FR)
Panpharma S.A., Luitre (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Levofloxacin, 5 mg/ml/100 ml
Panpharma S.A., Luitre (FR)
Panpharma S.A., Luitre (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium, 10 mg/ml, 2,5 ml
Panpharma S.A., Luitre (FR)
Panpharma S.A., Luitre (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Piperacillin and Tazobactam, 2 g and 0,25 g/50 ml
Panpharma S.A., Luitre (FR)
Panpharma S.A., Luitre (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl Citrate 50 mcg/ml, 10 ml
Panpharma S.A., Luitre (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Piperacillin and Tazobactam, 4 g and 0,5 g/100 ml
Panpharma S.A., Luitre (FR)
Panpharma S.A., Luitre (FR)
Panpharma S.A., Luitre (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium, 10 mg/ml, 5 ml
Panpharma S.A., Luitre (FR)
Panpharma S.A., Luitre (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 5 ml
Panpharma S.A., Luitre (FR)
Panpharma S.A., Luitre (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 10 ml
Panpharma S.A., Luitre (FR)
Panpharma S.A., Luitre (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Panpharma S.A., Luitre (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 10 mg/ml, 1 ml
Panpharma S.A., Luitre (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Panpharma S.A., Luitre (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Panpharma S.A., Luitre (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 4 ml
Panpharma S.A., Luitre (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 10 ml
Panpharma S.A., Luitre (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 1 mg/ml, 5 ml
Panpharma S.A., Luitre (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 2 mg/ml, 50 ml
Panpharma S.A., Luitre (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 1 ml
Panpharma S.A., Luitre (FR)
Panpharma S.A., Luitre (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 3 ml
Panpharma S.A., Luitre (FR)
Panpharma S.A., Luitre (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 10 mg/ml, 1 ml
Panpharma S.A., Luitre (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 10 ml
Panpharma S.A., Luitre (FR)
Panpharma S.A., Luitre (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 10 ml
Panpharma S.A., Luitre (FR)
Panpharma S.A., Luitre (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 50 ml
Panpharma S.A., Luitre (FR)
Panpharma S.A., Luitre (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 100 ml
Panpharma S.A., Luitre (FR)
Panpharma S.A., Luitre (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 20 mg/ml, 50 ml
Panpharma S.A., Luitre (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 20 mg/ml, 1 ml
Panpharma S.A., Luitre (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dopamine, 40 mg/ml, 5 ml
Panpharma S.A., Luitre (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Epinephrine/Adrenaline, 1 mg/ml, 1 ml
Panpharma S.A., Luitre (FR)
Panpharma S.A., Luitre (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 1 mg/ml,1 ml
Panpharma S.A., Luitre (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 1 mg/ml, 4 ml
Panpharma S.A., Luitre (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 2 mg/ml, 1 ml
Panpharma S.A., Luitre (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin, 5K/1 ml, 5 ml
Panpharma S.A., Luitre (FR)
Panpharma S.A., Luitre (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 50 mcg/ml 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 500 mcg/ml 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 20 mg/ml, 1 ml
Panpharma S.A., Luitre (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 50 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 60 mg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Amoxicillin sodium/Potassium clavulanate 1 g/100 mg/10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Levofloxacin 5 mg/ml/50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium 10 mg/ml, 25 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Mivacurium 2 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium 10 mg/1 ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine 100 mcg/ml 25 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Lorazepam 4 mg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam 5 mg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 30 mg/ml, 1ml
Panpharma S.A., Luitre (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol 10 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease - Dobutamine 50 mg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dobutamine 5 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dopamine 200 mg/1 ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Epinephrine/Adrenaline 1 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 80 mcg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 1 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin 25 IU/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin 100 IU/ ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 50 mcg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 100 mg/ml, 5 ml
Panpharma S.A., Luitre (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 2 mg/ml, 4 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 50 mcg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 5 mcg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 50 mcg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 2 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 10 ml
Panpharma S.A., Luitre (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Panpharma S.A., Luitre (FR)
Panpharma S.A., Luitre (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg /ml 2 ml
Panpharma S.A., Luitre (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Panpharma S.A., Luitre (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexamethasone 4 mg/ml, 1 ml
Panpharma S.A., Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Panpharma S.A., Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Panpharma S.A., Luitré (FR)
Panpharma S.A., Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 4 ml
Panpharma S.A., Luitré (FR)
Panpharma S.A., Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 10 ml
Panpharma S.A., Luitré (FR)
Panpharma S.A., Luitré (FR)
Panpharma S.A., Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 1 mg/ml, 5 ml
Panpharma S.A., Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 3 ml
Panpharma S.A., Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 50 ml
Panpharma S.A., Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Panpharma S.A., Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin, 5K/1 ml, 5 ml
Panpharma S.A., Luitré (FR)
Panpharma S.A., Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 5 ml
Panpharma S.A., Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Panpharma S.A., Luitré (FR)
Panpharma S.A., Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 1 mg
Panpharma S.A., Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 2 mg
Panpharma S.A., Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 5 mg
Panpharma S.A., Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Amoxicillin Sodium / Potassium Clavulanate 1 g/220 mg/10 ml
Panpharma S.A., Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Azithromycin 500 mg/5 ml
Panpharma S.A., Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 1 g/10 ml
Panpharma S.A., Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl Citrate 50 mcg/ml, 2 ml
Panpharma S.A., Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 1 g/10 ml
Panpharma S.A., Luitré (FR)
Panpharma S.A., Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 2 g/10 ml
Panpharma S.A., Luitré (FR)
Panpharma S.A., Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Levofloxacin, 5 mg/ml/100 ml
Panpharma S.A., Luitré (FR)
Panpharma S.A., Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium, 10 mg/ml, 2,5 ml
Panpharma S.A., Luitré (FR)
Panpharma S.A., Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Piperacillin and Tazobactam, 2 g and 0,25 g/50 ml
Panpharma S.A., Luitré (FR)
Panpharma S.A., Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl Citrate 50 mcg/ml, 10 ml
Panpharma S.A., Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Piperacillin and Tazobactam, 4 g and 0,5 g/100 ml
Panpharma S.A., Luitré (FR)
Panpharma S.A., Luitré (FR)
Panpharma S.A., Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium, 10 mg/ml, 5 ml
Panpharma S.A., Luitré (FR)
Panpharma S.A., Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 5 ml
Panpharma S.A., Luitré (FR)
Panpharma S.A., Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 10 ml
Panpharma S.A., Luitré (FR)
Panpharma S.A., Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Panpharma S.A., Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 10 mg/ml, 1 ml
Panpharma S.A., Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Panpharma S.A., Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Panpharma S.A., Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 4 ml
Panpharma S.A., Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 10 ml
Panpharma S.A., Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 1 mg/ml, 5 ml
Panpharma S.A., Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 2 mg/ml, 50 ml
Panpharma S.A., Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 1 ml
Panpharma S.A., Luitré (FR)
Panpharma S.A., Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 3 ml
Panpharma S.A., Luitré (FR)
Panpharma S.A., Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 10 mg/ml, 1 ml
Panpharma S.A., Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 10 ml
Panpharma S.A., Luitré (FR)
Panpharma S.A., Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 10 ml
Panpharma S.A., Luitré (FR)
Panpharma S.A., Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 50 ml
Panpharma S.A., Luitré (FR)
Panpharma S.A., Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 100 ml
Panpharma S.A., Luitré (FR)
Panpharma S.A., Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 20 mg/ml, 50 ml
Panpharma S.A., Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 20 mg/ml, 1 ml
Panpharma S.A., Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dopamine, 40 mg/ml, 5 ml
Panpharma S.A., Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Epinephrine/Adrenaline, 1 mg/ml, 1 ml
Panpharma S.A., Luitré (FR)
Panpharma S.A., Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 1 mg/ml,1 ml
Panpharma S.A., Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 1 mg/ml, 4 ml
Panpharma S.A., Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 2 mg/ml, 1 ml
Panpharma S.A., Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin, 5K/1 ml, 5 ml
Panpharma S.A., Luitré (FR)
Panpharma S.A., Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 50 mcg/ml 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 500 mcg/ml 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 20 mg/ml, 1 ml
Panpharma S.A., Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 50 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 60 mg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Amoxicillin sodium/Potassium clavulanate 1 g/100 mg/10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Levofloxacin 5 mg/ml/50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium 10 mg/ml, 25 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Mivacurium 2 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium 10 mg/1 ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine 100 mcg/ml 25 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Lorazepam 4 mg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam 5 mg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 30 mg/ml, 1ml
Panpharma S.A., Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol 10 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease - Dobutamine 50 mg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dobutamine 5 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dopamine 200 mg/1 ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Epinephrine/Adrenaline 1 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 80 mcg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 1 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin 25 IU/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin 100 IU/ ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 50 mcg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 100 mg/ml, 5 ml
Panpharma S.A., Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 2 mg/ml, 4 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 50 mcg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 5 mcg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 50 mcg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 2 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 10 ml
Panpharma S.A., Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Panpharma S.A., Luitré (FR)
Panpharma S.A., Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg /ml 2 ml
Panpharma S.A., Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Panpharma S.A., Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexamethasone 4 mg/ml, 1 ml
Panpharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Panpharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Panpharma SA, Luitré (FR)
Panpharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 4 ml
Panpharma SA, Luitré (FR)
Panpharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 10 ml
Panpharma SA, Luitré (FR)
Panpharma SA, Luitré (FR)
Panpharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 1 mg/ml, 5 ml
Panpharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 3 ml
Panpharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 50 ml
Panpharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Panpharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin, 5K/1 ml, 5 ml
Panpharma SA, Luitré (FR)
Panpharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 5 ml
Panpharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Panpharma SA, Luitré (FR)
Panpharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 1 mg
Panpharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 2 mg
Panpharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 5 mg
Panpharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Amoxicillin Sodium / Potassium Clavulanate 1 g/220 mg/10 ml
Panpharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Azithromycin 500 mg/5 ml
Panpharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 1 g/10 ml
Panpharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl Citrate 50 mcg/ml, 2 ml
Panpharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 1 g/10 ml
Panpharma SA, Luitré (FR)
Panpharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 2 g/10 ml
Panpharma SA, Luitré (FR)
Panpharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Levofloxacin, 5 mg/ml/100 ml
Panpharma SA, Luitré (FR)
Panpharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium, 10 mg/ml, 2,5 ml
Panpharma SA, Luitré (FR)
Panpharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Piperacillin and Tazobactam, 2 g and 0,25 g/50 ml
Panpharma SA, Luitré (FR)
Panpharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl Citrate 50 mcg/ml, 10 ml
Panpharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Piperacillin and Tazobactam, 4 g and 0,5 g/100 ml
Panpharma SA, Luitré (FR)
Panpharma SA, Luitré (FR)
Panpharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium, 10 mg/ml, 5 ml
Panpharma SA, Luitré (FR)
Panpharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 5 ml
Panpharma SA, Luitré (FR)
Panpharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 10 ml
Panpharma SA, Luitré (FR)
Panpharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Panpharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 10 mg/ml, 1 ml
Panpharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Panpharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Panpharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 4 ml
Panpharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 10 ml
Panpharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 1 mg/ml, 5 ml
Panpharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 2 mg/ml, 50 ml
Panpharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 1 ml
Panpharma SA, Luitré (FR)
Panpharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 3 ml
Panpharma SA, Luitré (FR)
Panpharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 10 mg/ml, 1 ml
Panpharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 10 ml
Panpharma SA, Luitré (FR)
Panpharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 10 ml
Panpharma SA, Luitré (FR)
Panpharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 50 ml
Panpharma SA, Luitré (FR)
Panpharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 100 ml
Panpharma SA, Luitré (FR)
Panpharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 20 mg/ml, 50 ml
Panpharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 20 mg/ml, 1 ml
Panpharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dopamine, 40 mg/ml, 5 ml
Panpharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Epinephrine/Adrenaline, 1 mg/ml, 1 ml
Panpharma SA, Luitré (FR)
Panpharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 1 mg/ml,1 ml
Panpharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 1 mg/ml, 4 ml
Panpharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 2 mg/ml, 1 ml
Panpharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin, 5K/1 ml, 5 ml
Panpharma SA, Luitré (FR)
Panpharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 50 mcg/ml 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 500 mcg/ml 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 20 mg/ml, 1 ml
Panpharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 50 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 60 mg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Amoxicillin sodium/Potassium clavulanate 1 g/100 mg/10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Levofloxacin 5 mg/ml/50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium 10 mg/ml, 25 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Mivacurium 2 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium 10 mg/1 ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine 100 mcg/ml 25 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Lorazepam 4 mg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam 5 mg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 30 mg/ml, 1ml
Panpharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol 10 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease - Dobutamine 50 mg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dobutamine 5 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dopamine 200 mg/1 ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Epinephrine/Adrenaline 1 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 80 mcg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 1 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin 25 IU/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin 100 IU/ ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 50 mcg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 100 mg/ml, 5 ml
Panpharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 2 mg/ml, 4 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 50 mcg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 5 mcg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 50 mcg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 2 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 10 ml
Panpharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Panpharma SA, Luitré (FR)
Panpharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg /ml 2 ml
Panpharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Panpharma SA, Luitré (FR)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexamethasone 4 mg/ml, 1 ml
Sandoz D.D., Ljubljana (SI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Sandoz D.D., Ljubljana (SI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Sandoz D.D., Ljubljana (SI)
Sandoz D.D., Ljubljana (SI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 4 ml
Sandoz D.D., Ljubljana (SI)
Sandoz D.D., Ljubljana (SI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 10 ml
Sandoz D.D., Ljubljana (SI)
Sandoz D.D., Ljubljana (SI)
Sandoz D.D., Ljubljana (SI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 1 mg/ml, 5 ml
Sandoz D.D., Ljubljana (SI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 3 ml
Sandoz D.D., Ljubljana (SI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 50 ml
Sandoz D.D., Ljubljana (SI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Sandoz D.D., Ljubljana (SI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin, 5K/1 ml, 5 ml
Sandoz D.D., Ljubljana (SI)
Sandoz D.D., Ljubljana (SI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 5 ml
Sandoz D.D., Ljubljana (SI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Sandoz D.D., Ljubljana (SI)
Sandoz D.D., Ljubljana (SI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 1 mg
Sandoz D.D., Ljubljana (SI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 2 mg
Sandoz D.D., Ljubljana (SI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 5 mg
Sandoz D.D., Ljubljana (SI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Amoxicillin Sodium / Potassium Clavulanate 1 g/220 mg/10 ml
Sandoz D.D., Ljubljana (SI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Azithromycin 500 mg/5 ml
Sandoz D.D., Ljubljana (SI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 1 g/10 ml
Sandoz D.D., Ljubljana (SI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl Citrate 50 mcg/ml, 2 ml
Sandoz D.D., Ljubljana (SI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 1 g/10 ml
Sandoz D.D., Ljubljana (SI)
Sandoz D.D., Ljubljana (SI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 2 g/10 ml
Sandoz D.D., Ljubljana (SI)
Sandoz D.D., Ljubljana (SI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Levofloxacin, 5 mg/ml/100 ml
Sandoz D.D., Ljubljana (SI)
Sandoz D.D., Ljubljana (SI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium, 10 mg/ml, 2,5 ml
Sandoz D.D., Ljubljana (SI)
Sandoz D.D., Ljubljana (SI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Piperacillin and Tazobactam, 2 g and 0,25 g/50 ml
Sandoz D.D., Ljubljana (SI)
Sandoz D.D., Ljubljana (SI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl Citrate 50 mcg/ml, 10 ml
Sandoz D.D., Ljubljana (SI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Piperacillin and Tazobactam, 4 g and 0,5 g/100 ml
Sandoz D.D., Ljubljana (SI)
Sandoz D.D., Ljubljana (SI)
Sandoz D.D., Ljubljana (SI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium, 10 mg/ml, 5 ml
Sandoz D.D., Ljubljana (SI)
Sandoz D.D., Ljubljana (SI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 5 ml
Sandoz D.D., Ljubljana (SI)
Sandoz D.D., Ljubljana (SI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 10 ml
Sandoz D.D., Ljubljana (SI)
Sandoz D.D., Ljubljana (SI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Sandoz D.D., Ljubljana (SI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 10 mg/ml, 1 ml
Sandoz D.D., Ljubljana (SI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Sandoz D.D., Ljubljana (SI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Sandoz D.D., Ljubljana (SI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 4 ml
Sandoz D.D., Ljubljana (SI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 10 ml
Sandoz D.D., Ljubljana (SI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 1 mg/ml, 5 ml
Sandoz D.D., Ljubljana (SI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 2 mg/ml, 50 ml
Sandoz D.D., Ljubljana (SI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 1 ml
Sandoz D.D., Ljubljana (SI)
Sandoz D.D., Ljubljana (SI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 3 ml
Sandoz D.D., Ljubljana (SI)
Sandoz D.D., Ljubljana (SI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 10 mg/ml, 1 ml
Sandoz D.D., Ljubljana (SI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 10 ml
Sandoz D.D., Ljubljana (SI)
Sandoz D.D., Ljubljana (SI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 10 ml
Sandoz D.D., Ljubljana (SI)
Sandoz D.D., Ljubljana (SI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 50 ml
Sandoz D.D., Ljubljana (SI)
Sandoz D.D., Ljubljana (SI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 100 ml
Sandoz D.D., Ljubljana (SI)
Sandoz D.D., Ljubljana (SI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 20 mg/ml, 50 ml
Sandoz D.D., Ljubljana (SI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 20 mg/ml, 1 ml
Sandoz D.D., Ljubljana (SI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dopamine, 40 mg/ml, 5 ml
Sandoz D.D., Ljubljana (SI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Epinephrine/Adrenaline, 1 mg/ml, 1 ml
Sandoz D.D., Ljubljana (SI)
Sandoz D.D., Ljubljana (SI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 1 mg/ml,1 ml
Sandoz D.D., Ljubljana (SI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 1 mg/ml, 4 ml
Sandoz D.D., Ljubljana (SI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 2 mg/ml, 1 ml
Sandoz D.D., Ljubljana (SI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin, 5K/1 ml, 5 ml
Sandoz D.D., Ljubljana (SI)
Sandoz D.D., Ljubljana (SI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 50 mcg/ml 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 500 mcg/ml 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 20 mg/ml, 1 ml
Sandoz D.D., Ljubljana (SI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 50 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 60 mg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Amoxicillin sodium/Potassium clavulanate 1 g/100 mg/10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Levofloxacin 5 mg/ml/50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium 10 mg/ml, 25 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Mivacurium 2 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium 10 mg/1 ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine 100 mcg/ml 25 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Lorazepam 4 mg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam 5 mg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 30 mg/ml, 1ml
Sandoz D.D., Ljubljana (SI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol 10 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease - Dobutamine 50 mg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dobutamine 5 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dopamine 200 mg/1 ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Epinephrine/Adrenaline 1 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 80 mcg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 1 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin 25 IU/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin 100 IU/ ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 50 mcg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 100 mg/ml, 5 ml
Sandoz D.D., Ljubljana (SI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 2 mg/ml, 4 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 50 mcg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 5 mcg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 50 mcg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 2 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 10 ml
Sandoz D.D., Ljubljana (SI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Sandoz D.D., Ljubljana (SI)
Sandoz D.D., Ljubljana (SI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg /ml 2 ml
Sandoz D.D., Ljubljana (SI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Sandoz D.D., Ljubljana (SI)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexamethasone 4 mg/ml, 1 ml
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 4 ml
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 10 ml
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 1 mg/ml, 5 ml
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 3 ml
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 50 ml
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin, 5K/1 ml, 5 ml
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 5 ml
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 1 mg
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 2 mg
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 5 mg
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Amoxicillin Sodium / Potassium Clavulanate 1 g/220 mg/10 ml
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Azithromycin 500 mg/5 ml
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 1 g/10 ml
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl Citrate 50 mcg/ml, 2 ml
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 1 g/10 ml
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 2 g/10 ml
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Levofloxacin, 5 mg/ml/100 ml
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium, 10 mg/ml, 2,5 ml
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Piperacillin and Tazobactam, 2 g and 0,25 g/50 ml
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl Citrate 50 mcg/ml, 10 ml
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Piperacillin and Tazobactam, 4 g and 0,5 g/100 ml
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium, 10 mg/ml, 5 ml
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 5 ml
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 10 ml
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 10 mg/ml, 1 ml
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 4 ml
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 10 ml
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 1 mg/ml, 5 ml
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 2 mg/ml, 50 ml
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 1 ml
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 3 ml
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 10 mg/ml, 1 ml
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 10 ml
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 10 ml
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 50 ml
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 100 ml
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 20 mg/ml, 50 ml
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 20 mg/ml, 1 ml
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dopamine, 40 mg/ml, 5 ml
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Epinephrine/Adrenaline, 1 mg/ml, 1 ml
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 1 mg/ml,1 ml
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 1 mg/ml, 4 ml
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 2 mg/ml, 1 ml
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin, 5K/1 ml, 5 ml
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 50 mcg/ml 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 500 mcg/ml 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 20 mg/ml, 1 ml
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 50 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 60 mg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Amoxicillin sodium/Potassium clavulanate 1 g/100 mg/10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Levofloxacin 5 mg/ml/50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium 10 mg/ml, 25 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Mivacurium 2 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium 10 mg/1 ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine 100 mcg/ml 25 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Lorazepam 4 mg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam 5 mg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 30 mg/ml, 1ml
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol 10 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease - Dobutamine 50 mg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dobutamine 5 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dopamine 200 mg/1 ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Epinephrine/Adrenaline 1 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 80 mcg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 1 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin 25 IU/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin 100 IU/ ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 50 mcg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 100 mg/ml, 5 ml
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 2 mg/ml, 4 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 50 mcg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 5 mcg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 50 mcg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 2 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 10 ml
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg /ml 2 ml
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Sun Pharmaceutical Industries Europe BV, Hoofddorp (NL)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexamethasone 4 mg/ml, 1 ml
Tillomed Laboratories Limited, Luton (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Tillomed Laboratories Limited, Luton (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Tillomed Laboratories Limited, Luton (UK)
Tillomed Laboratories Limited, Luton (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 4 ml
Tillomed Laboratories Limited, Luton (UK)
Tillomed Laboratories Limited, Luton (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 10 ml
Tillomed Laboratories Limited, Luton (UK)
Tillomed Laboratories Limited, Luton (UK)
Tillomed Laboratories Limited, Luton (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 1 mg/ml, 5 ml
Tillomed Laboratories Limited, Luton (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 3 ml
Tillomed Laboratories Limited, Luton (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 50 ml
Tillomed Laboratories Limited, Luton (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Tillomed Laboratories Limited, Luton (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin, 5K/1 ml, 5 ml
Tillomed Laboratories Limited, Luton (UK)
Tillomed Laboratories Limited, Luton (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 5 ml
Tillomed Laboratories Limited, Luton (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Paracetamol, 10 mg/ml, 100 ml
Tillomed Laboratories Limited, Luton (UK)
Tillomed Laboratories Limited, Luton (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 1 mg
Tillomed Laboratories Limited, Luton (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 2 mg
Tillomed Laboratories Limited, Luton (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Remifentanil, 5 mg
Tillomed Laboratories Limited, Luton (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Amoxicillin Sodium / Potassium Clavulanate 1 g/220 mg/10 ml
Tillomed Laboratories Limited, Luton (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Azithromycin 500 mg/5 ml
Tillomed Laboratories Limited, Luton (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 1 g/10 ml
Tillomed Laboratories Limited, Luton (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl Citrate 50 mcg/ml, 2 ml
Tillomed Laboratories Limited, Luton (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 1 g/10 ml
Tillomed Laboratories Limited, Luton (UK)
Tillomed Laboratories Limited, Luton (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Ceftriaxone, 2 g/10 ml
Tillomed Laboratories Limited, Luton (UK)
Tillomed Laboratories Limited, Luton (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Levofloxacin, 5 mg/ml/100 ml
Tillomed Laboratories Limited, Luton (UK)
Tillomed Laboratories Limited, Luton (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium, 10 mg/ml, 2,5 ml
Tillomed Laboratories Limited, Luton (UK)
Tillomed Laboratories Limited, Luton (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Piperacillin and Tazobactam, 2 g and 0,25 g/50 ml
Tillomed Laboratories Limited, Luton (UK)
Tillomed Laboratories Limited, Luton (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl Citrate 50 mcg/ml, 10 ml
Tillomed Laboratories Limited, Luton (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Piperacillin and Tazobactam, 4 g and 0,5 g/100 ml
Tillomed Laboratories Limited, Luton (UK)
Tillomed Laboratories Limited, Luton (UK)
Tillomed Laboratories Limited, Luton (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium, 10 mg/ml, 5 ml
Tillomed Laboratories Limited, Luton (UK)
Tillomed Laboratories Limited, Luton (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 5 ml
Tillomed Laboratories Limited, Luton (UK)
Tillomed Laboratories Limited, Luton (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 10 ml
Tillomed Laboratories Limited, Luton (UK)
Tillomed Laboratories Limited, Luton (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Tillomed Laboratories Limited, Luton (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 10 mg/ml, 1 ml
Tillomed Laboratories Limited, Luton (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Tillomed Laboratories Limited, Luton (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Tillomed Laboratories Limited, Luton (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 4 ml
Tillomed Laboratories Limited, Luton (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 10 ml
Tillomed Laboratories Limited, Luton (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 1 mg/ml, 5 ml
Tillomed Laboratories Limited, Luton (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 2 mg/ml, 50 ml
Tillomed Laboratories Limited, Luton (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 1 ml
Tillomed Laboratories Limited, Luton (UK)
Tillomed Laboratories Limited, Luton (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 3 ml
Tillomed Laboratories Limited, Luton (UK)
Tillomed Laboratories Limited, Luton (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 10 mg/ml, 1 ml
Tillomed Laboratories Limited, Luton (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 10 ml
Tillomed Laboratories Limited, Luton (UK)
Tillomed Laboratories Limited, Luton (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 10 ml
Tillomed Laboratories Limited, Luton (UK)
Tillomed Laboratories Limited, Luton (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 50 ml
Tillomed Laboratories Limited, Luton (UK)
Tillomed Laboratories Limited, Luton (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 10 mg/ml, 100 ml
Tillomed Laboratories Limited, Luton (UK)
Tillomed Laboratories Limited, Luton (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol, 20 mg/ml, 50 ml
Tillomed Laboratories Limited, Luton (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 20 mg/ml, 1 ml
Tillomed Laboratories Limited, Luton (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dopamine, 40 mg/ml, 5 ml
Tillomed Laboratories Limited, Luton (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Epinephrine/Adrenaline, 1 mg/ml, 1 ml
Tillomed Laboratories Limited, Luton (UK)
Tillomed Laboratories Limited, Luton (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 1 mg/ml,1 ml
Tillomed Laboratories Limited, Luton (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 1 mg/ml, 4 ml
Tillomed Laboratories Limited, Luton (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline, 2 mg/ml, 1 ml
Tillomed Laboratories Limited, Luton (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin, 5K/1 ml, 5 ml
Tillomed Laboratories Limited, Luton (UK)
Tillomed Laboratories Limited, Luton (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 50 mcg/ml 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 500 mcg/ml 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 20 mg/ml, 1 ml
Tillomed Laboratories Limited, Luton (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 50 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 60 mg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Amoxicillin sodium/Potassium clavulanate 1 g/100 mg/10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Levofloxacin 5 mg/ml/50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Atracurium 10 mg/ml, 25 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Mivacurium 2 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium 10 mg/1 ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine 100 mcg/ml 25 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Lorazepam 4 mg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam 5 mg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine 30 mg/ml, 1ml
Tillomed Laboratories Limited, Luton (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Propofol 10 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease - Dobutamine 50 mg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dobutamine 5 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dopamine 200 mg/1 ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Epinephrine/Adrenaline 1 mg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 80 mcg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 1 mg/ml, 50 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin 25 IU/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Heparin 100 IU/ ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Fentanyl 50 mcg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Morphine, 100 mg/ml, 5 ml
Tillomed Laboratories Limited, Luton (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Norepinephrine/Noradrenaline 2 mg/ml, 4 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 50 mcg/ml, 1 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 5 mcg/ml, 10 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Sufentanil, 50 mcg/ml, 5 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Midazolam, 5 mg/ml, 2 ml
Contract not awarded
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Cisatracurium, 2 mg/ml, 10 ml
Tillomed Laboratories Limited, Luton (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Rocuronium, 10 mg/ml, 5 ml
Tillomed Laboratories Limited, Luton (UK)
Tillomed Laboratories Limited, Luton (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg /ml 2 ml
Tillomed Laboratories Limited, Luton (UK)
Supply of Medicinal Products Used for Intensive Care Patients Subject to COVID-19 Disease – Dexmedetomidine, 100 mcg/ml 2 ml
Tillomed Laboratories Limited, Luton (UK)
Download full details as .pdf
The Buyer:
European Commission, Directorate-General for Health and Food Safety (SANTE), Unit C3 Health Security
CPV Code(s):
33600000 - Pharmaceutical products
33631400 - Antibiotics and chemotherapeutics for dermatological use
33632200 - Muscle relaxants
33650000 - General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents
33652300 - Immunosuppressive agents
33661100 - Anaesthetics
33661200 - Analgesics
33690000 - Various medicinal products